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Abstract 
The skin functions as a biologically active barrier separating the internal milieu from the 
external environment. It is the body's first line of defense against external trauma and has 
evolved to detect, integrate and respond to a great variety of stressors including solar 
radiation. It has been shown that levels of sunlight attained during normal daily activities are 
mutagenic, and that exposure to the ultraviolet (UV) component of sunlight, specifically the 
long wavelength UV A (315-400 nm), may lead to photocarcinogenesis and photoaging. 
UV A-induced skin damage occurs mainly indirectly through oxidative processes initiated by 
endogenous photosensitization. The increase in intracellular reactive oxygen species (ROS) 
induced by UV A may overwhelm the cells antioxidant capacity, leading to oxidative stress. 
As continued oxidative stress may lead to cell death via apoptosis or necrosis, it is hereby 
hypothesized that the pre-treatment of cells with exogenous antioxidants could be effective 
in reducing oxidative stress. The combination of ferulic acid, a botanically-derived 
antioxidant, with vitamins C and E has been shown to provide a photoprotective effect in 
porcine skin, illustrating that the incorporation of antioxidants into photoprotective agents 
may be a feasible option for combating UVA-mediated oxidative damage. 
This study assessed the ability of 0.8 mM ferulic acid (FA), in combination with vitamins C 
and E, to reduce the effect of UVA-induced photodamage in human epidermal (HaCaTs) 
and dermal skin cells (primary human fibroblasts (HFbs) and murine 3T3 cells). Pre-
treatment with the FA and vitamins C and E (vEC) combination solution reduced UVA-
induced ROS in human fibroblasts while pre-treatment with vEC individually led to a 
reduction in HaCaTs. As exposure to UV A may also lead to an increase in lipid 
peroxidation, it was believed that antioxidant pre-exposure may lead to a reduction in ROS 
and subsequent reduction in lipid peroxidation. The thiobarbituric acid reactive substances 
(TBARS) and conjugated diene assay were used to measure lipid peroxidation. Pre-
treatment with vEC led to an apparent reduction in conjugated diene levels in HaCaTs, but 
the data did not correlate with the ROS result in the HFbs. As prolonged oxidative stress 











UV A-induced cell death. The cell viability assay showed treatment had no effect on cell 
death in HaCaTs and 3T3 cells, yet appeared to confer some degree of protection to HFbs. 
Analysis of the mode of cell death using Annexin VI propidium iodide staining showed that 
HaCaTs were predominantly dying by apoptosis. It was determined the human fibroblasts 
were largely dying by necrosis after 2 h and by apoptosis after 4, 12 and 24 h. Pre-treating 
the HFbs with vEC alone was able to maintain a level of viability similar to control cells 
after 24 h. To further understand the mechanisms of apoptotic cell death in HFbs, two 
apoptosis-associated proteins, anti-apoptotic Bcl-2 and pro-apoptotic Bax, were investigated. 
Their ratio (BcI-2:Bax) is indicative of survival, however no significant trends were 
established and further assays are required to determine conclusive results. 
Ferulic acid, in combination with vitamins C and E, has been shown to be effective as a 
photoprotective agent in vivo. The findings of this study have shown that although the 
antioxidants have little effect in the epidermal keratinoeytes, they show great potential in the 
dermal fibroblasts, whieh is very important with regards to photoaging. Future studies 
investigating the effect of the antioxidants on UV A-induced DNA and protein damage will 
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melanin serves as a form of photoprotection against DNA damage by forming a 
supranuclear melanin cap around the keratinocyte nucleus 13. 14. 
The layer above the stratum basale is known as the stratum sp1l10sum (figure 1.2). This 
'prickle cell layer' consists of relatively large, polyhedral shaped keratinocytes, as well as 
bone-marrow derived sentinel cells of the immune system called Langerhans cells. These 
epidermal antigen presenting cells are also able to express some neuronal markers, as well as 
neuropeptide receptors, and are key in providing the link between the neuroendocrine and 
. . h k' 3 15 16 17 a L h II . 'bl f' h' Immune systems 111 t e s 111 .. • . . ne anger ans ce IS responsl e lor t e Immune 
surveillance of fifty-three surrounding epidermal cells 18. The next layer, the stratum 
granulosum, contains keratinocytes that develop a flattened morphology as dividing cells 
below push them towards the skin surface. The uppermost layer, the stratum corneum, 
comprises 15-30 sheets of non-viable, but biochemically active cells called corneocytes 1. 
This layer is the principal barrier to the percutaneous penetration of exogenous substances, 
and has well established antimicrobial, chemical and antioxidant defense mechanisms 2. 19. 
1.1.2 The Dermis 
Dermal tissue is separated from the overlying epidermis by a cutaneous basement membrane 
(figure 1.1). This specialized membrane plays an important role in normal skin functioning 
as well as a key part in pathological processes such as wound healing and tumour cell 
invasion 20. The dermis itself may be divided into the papillary and reticular dermis, 
reflecting their respective composition of connective tissue components, cell number, and 
supply of blood vessels and nerves 1. Dermal cell populations include fibroblasts, 
adipocytes, macrophages, mast cells, Langerhans cells, T lymphocytes, dendrocytes, smooth 
muscle cells and vascular and lymphatic endothelial cells 3. 
In vertebrates, connective tissue is functionally designed to provide a structural scaffold for 
vessels and cells, the principle cell type being fibroblasts 21. Dermal fibroblasts play an 











production of extracellular matrix (ECM) proteins 22 chemokines 23 and matrix 
II . "-I d I . I' d h I' 1 '1 meta oprotemases - ,an p ay major ro es m woun ea lI1g . - . 
The mature epidermis is reliant on the meticulous balance of keratinocyte proliferation and 
differentiation, which is tightly regulated via a cytokine expression network between 
keratinocytes and adjacent fibroblasts 25, 26 during both skin development and regeneration 
27. 28, The manner in which keratinocytes and fibroblasts interact is via a double paracrine 
system 29. Keratinocytes produce factors such as the cytokine interleukin-l (IL-l) 30, which 
in turn induces growth factor expression in fibroblasts 31. Keratinocyte growth factor (KGF) 
and other fibroblast-derived mitogens are then responsible for the regulation of keratinocyte 
proliferation and differentiation 32. 
1.2 Skin Cancer and Photoaging 
The skin is by design resistant to most external traumas; however over-exposure to certain 
environmental insults such as ultraviolet (UY) radiation may result in cancer formation 33, 34, 
Skin cancer is the most common cancer in South Africa, with approximately 20 000 new 
cases reported each year 35, In addition, South Africa has the second highest incidence of 
skin cancer in the world behind Australia 35, 
Skin cancers are clinically classified as melanoma and non-melanoma skin cancer (NMSC), 
as determined by the original epidermal cell from which the cancer stems. Non-melanoma 
skin cancer can be further subdivided into basal cell (BCC) and squamous cell carcinoma 
(SCC). Both BCC and SCC arise from the basal layer of the epidermis, with BCC having a 
slow progression, and SCC being highly invasive and metastatic 36. BCC is the most 
common skin cancer and the most common human malignancy in general 37. BCCs and 
SCCs account for approximately 80% and 16% of all skin cancers respectively, while 











The main aetiological cause of skin cancer is exposure to UV radiation, primarily from 
sunlight 33. 3'+. 39. '+0. It has been shown that as well as chronic exposure to sunlight, levels of 
exposure achievable during normal daily activities are mutagenic '+1. In an attempt to protect 
itself from further UV damage, the skin responds to sun exposure by tanning '+2. The degree 
of skin pigmentation and the ability to tan are crucial factors in the development of skin 
cancer, and the risk of NMSC is highest in people who sunburn easily and fail to tan 
effectively '+3. The predominant acute effects of UV -irradiation on normal human skin 
include sunburn, inflammation (erythema), tanning and local or systemic 
immunosuppression. Chronic exposure leads to photoaging, immunosuppression and 
1 . 1 h . . 44 45 h ff f . .. u tlmate y p otocarcmogenesls . '. T e numerous e ects 0 UV-Irradlatlon are 
consequential of specific wavelengths that result in different cellular damages and 
subsequent responses 46. 47. 
Exposure of the skin to the UV component of sunlight, specifically the long wavelength 
UVA, has been shown to initiate two of the key pathways leading to photoaging, namely the 
induction of matrix metalloproteinases (MMPs) (the enzymes responsible for the 
degradation of the extracellular matrix) 48 and mutations in mitochondrial DNA 49. 50. 
Mutations in mitochondrial DNA have been recognized in degenerative diseases and also 
found to playa role in skin photoaging 49. 50. The harmful effect of UV A in generating 
mitochondrial DNA mutations and inducing MMPs is well documented in human dermal 
fibroblasts 50. 51. 
1.3 Ultraviolet Radiation 
Sunlight is composed of a continuous spectrum of electromagnetic radiation that is divided 
into three main parts based on different wavelengths: ultraviolet (5%), visible (50%) and 
infrared (45%) (figure 1.3) 52. The solar UV spectrum occurs between 100-400 nm. It is 
subdivided into short wave UVC (100-280 nm), medium wave UVB (280-315 nm) and long 
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UV -carcinogenesis due to its high penetration properties. Compared to UVB, UV A is about 
1000 times more effective in the production of an immediate tanning response, and is 
considerably more efficient in penetrating the actively dividing cells of the epidermal basal 
layer, as well as the fibroblasts of the underlying dermis 52. 63. 67. 68. UVA radiation has been 
shown to be mutagenic in cultured cells 63, including human fibroblasts 69, and able to 
induce melanomas 70 and SCCs 71 in mice. In 2006, He et al. illustrated that chronic 
exposure to UV A alone was adequate to induce a malignant phenotype in cultured human 
keratinocytes -l1. It has also been shown that during normal daily activities, exposure to UV A 
levels within sunlight sufficiently generates mutations of the tumour suppressor gene p53 in 
the basal layer of the epidermis 72. 
1.4 UVA-Induced Damage 
1.4.1 Indirect Mechanism 
At the cellular level, UVA is only weakly absorbed by DNA 73, and the majority of UVA-
induced damage occurs indirectly through oxidative processes initiated by endogenous 
photosensitization. Endogenous photosensitizers are cellular chromophores that include 
flavins74, certain sterols75 , aromatic amino acids76, NAD(P)H, porphyrins, heme 77 and 
urocanic acid, which occurs at high levels in the stratum corneum 78. 79. 
1.4.2 DNA damage 
UVA's ability to damage DNA is primarily due to excitation of non-DNA chromophores, 
leading to increased reactive oxygen species (ROS), which subsequently result in oxidative 
base damage 61. 80. 81. ROS can induce numerous covalent modifications to DNA, including 
single-nucleobase lesions, strand breaks, inter- and intrastrand cross-links and protein-DNA 
cross-links 82. It has also been shown that UV A exposure leads to persistent genomic 
instability in human keratinocytes 83. Work performed by Peak and Peak (1991) 
demonstrated that UVA is substantially more effective than shorter wavelength UVR in 











repair of SSB in cultured human fibroblasts after UV A irradiation appears to be a very rapid 
process, with 90% being removed within 15 min of exposure 85. 
It was initially believed that photodimeric CPOs and 6,4-PPs, which are responsible for 
single or tandem cytosine to thymine trans versions, would not be expected to occur in DNA 
exposed to UV A. There is evidence to support this theory 86, yet a multitude of studies have 
shown CPOs to be a major pre-mutagenic lesion in UVA-induced mutagenesis 8\. 87. 88. 89. 90. 
9\. 92. 93. 94. 95. 96. It has been suggested that UV A induces these CPOs by a photosensitized 
triplet energy transfer in contrast to the direct excitation of DNA by UVB 81. 92. 
1.4.3 Protein Damage 
Proteins are major molecular targets for oxidative damage within cells, owing to their high 
abundance (comprising about 68% of the dry weight of cells) and rapid reaction rates with 
radicals and excited-state species such as singlet oxygen 97. ROS cause modifications to 
amino acids that frequently result in functional changes of structural or enzymatic 
proteins 98. The formation of modified proteins as a result of singlet oxygen-mediated photo-
oxidation may lead to critical changes in the properties and function of these proteins, 
induce structural alterations such as protein cross-linking 99 and lead to a change in 
susceptibility of the oxidised protein to proteolytic enzymes 100. The oxidation of critical 
methionine residues (methionine sulfoxide) may lead to the inactivation of certain proteins, 
and the reduction of this oxidised amino acid appears to be crucial for cell survival in the 
presence of ROS 101. The peptide methionine sulfoxide reductase A (MSRA) is a repair 
enzyme that is able to reduce methionine sulfoxide, and has been found to be upregulated by 
UV A exposure and represents the only enzyme thus far identified in human skin that is able 
to repair oxidative protein damage 102. 
The detection of carbonyl groups m the skin is commonly used as a marker of ROS 
d· d . 'd' 1m 104 105 P . bIb' d d' . me late protem OXI atlOn .. . . rotem car ony s may e mtro uce mto protems 
through reactions with reactive carbonyl derivatives formed from the reaction of reducing 











hydroxy-2-nonenal (4-HNE) or malondialdehyde (MDA)) during lipid peroxidation 106, 
UV A-irradiation of human fibroblasts results in increased protein oxidation, illustrated by a 
dose-dependent increase in the amount of protein carbonyls 6-1, 
1.4.4 Lipid Damage 
Like nucleic acids and proteins, unsaturated lipids are prominent targets of free radical 
attack in cells that are under photo-oxidative stress, It has been shown that UVA radiation is 
the most proficient UVR in triggering the peroxidation response 65, Lipid peroxidation is 
initiated by free radical (e,g, hydroxyl radical) attack on a fatty acid or fatty acid side chain 
that has sufficient reactivity to abstract a hydrogen atom from a methylene carbon in the side 
chain 107 (figure 1.4), The greater the amount of double bonds present in fatty acid side 
chains the easier the abstraction of a hydrogen atom, making polyunsaturated fatty acids 
(PUFAs) ideal targets for peroxidation, The removal of a hydrogen atom from one of these 
bonds yields a carbon-centred lipid radical that subsequently interacts with molecular 
oxygen to form a peroxyl radical. The resulting peroxyl radical is able to damage membrane 
proteins, or abstract hydrogen from adjacent fatty acid side chains which results in a chain 
, f I' 'd 'd' 107 108 109 Th I ' I' 'd h d 'd j: d' reactIOn 0 Ipl peroxl atlOn ' , , e resu tmg Ipl y roperoxl e lorme IS 
unstable, and can decompose to various species including MDA, or be reduced to a more 
stable alcohol form 110 (figure 1.4), 
The degree of lipid oxidation can be determined by measuring losses of unsaturated fatty 
acids, amounts of primary peroxidation products or amounts of secondary products such as 
carbonyls and hydrocarbon gases 107, Early peroxidation of unsaturated fatty acids is 
accompanied by the generation of conjugated diene structures (figure 1.4), which absorb UV 
light between 230-235 nm, and can be detected spectrophotometrically 107, MDA 
(figure 1.4) is used as a convenient biomarker for lipid peroxidation due to its simplistic 
reaction with thiobarbituric acid (thiobarbituric acid reactive substances (TBARS) assay) to 
form an intense pink chromogen, which can be measured at an absorbance of 532 nm 107, It 
has been shown that UV A-irradiation results in an increase in the amount of MDA in both 










relevant doses is capable of increasing MDA levels via pathways involving iron and singlet 
oxygen 112, It has been further shown that lipid peroxidation in human fibroblasts is involved 
in UV A-induced MMP-I activation, which plays a role in skin aging and cancer 113, 
o 
I. o 
Fatty acid with 3 double bonds 
1 -~ Hydrogen abstraction by hydroxyl radical 
Unstable carbon radical 
1 Molecular rearrangement 
Conjugated diene* 
1 Oxygen uptake 
Peroxyl radical 
1 +H Hydrogen abstraction ~ Chain reaction 
Lipid hydroperoxide 
Figure 1.4 Schematic representation of lipid peroxidation in poly-unsaturated fatty acids 114, 
Stars indicate the lipid peroxidation products detected in this study, 
1.5 Free Radicals and Reactive Oxygen Species 
1.5.1 Free Radicals 
Free radicals may be defined as 'any species capable of independent existence that contains 
one of more unpaired electrons' 115, Radicals may be formed by a non-radical losing or 
gaining a single electron 115, 
Gerschman's free radical theory of oxygen toxicity, which states that the toxicity of oxygen 
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oxygen poisoning 116. The realm of free radicals in biological systems was soon thereafter 
explored by Denham Harman, who hypothesized that oxygen radicals may be formed as by-
products of enzymatic reactions in vivo 117. Harman held free radicals accountable for major 
cellular damage, mutagenesis and cancer, as well as the degenerative process of biological 
. 117 118 Th' f f d' I . I' . . d d f agmg . . e sCIence 0 ree ra Ica S m Ivmg systems game renewe momentum a ter 
convincing evidence about their importance was proclaimed following the discovery of 
superoxide dismutase in 1969 119. 
1.5.2 Reactive Oxygen Species 
Reactive oxygen species (ROS) are natural by-products of normal cellular metabolism, 
formed principally through the reduction of molecular oxygen. Molecular oxygen, also 
known as dioxygen (02), in its ground state, contains two unpaired electrons which lead to 
preferential reduction via a univalent pathway (figure 1.5). The intermediates formed along 
this pathway include superoxide (02"-), hydrogen peroxide (H20 2) and the highly volatile 
hydroxyl radical (HO") 80 (figure 1.5). 
Figure 1.5 Molecular representation of the univalent reduction of oxygen. O2 (dioxygen), 
O2"- (superoxide), H20 2 (hydrogen peroxide), HO" (hydroxyl radical) and H20 (water). 
ROS include radical specIes, such as superoxide and hydroxyl radical, along with non-
radical species such as hydrogen peroxide 120 (table 1.1). Most of the ROS produced by cells 
occur mainly through four endogenous sources: aerobic respiration (mitochondria 
sequentially reduce oxygen to water) 121. 122, destruction of bacteria or virus-infected cells 
with an oxidative burst by phagocytic cells 123, peroxisomes (organelles that degrade fatty 
acids and produce hydrogen peroxide as a by-product) 124 and cytochrome P4S0 enzymes 











I !l I i (\ d l! , 1. i () 
noteworthy source of ROS comes from the two-step reaction catalysed by the xanthine 
oxidase (XO), whereby hypoxanthine is converted to xanthine, forming superoxide, and 
h·· d··d t' . h d ·d 117 1"8 E xant Ine IS converte to UrIC aCI , ormIng y rogen peroxI e -. ". xogenous sources 
that lead to ROS production include x-ray, gamma-ray and UV light irradiation 129. 
Table 1.1 Radical and non-radical reactive oxygen species 115. 
Free radicals Non-radicals 
Superoxide O2.' Hydrogen peroxide H20 2 
Hydroxyl HO· Hypobromous acid HOBr 
Hydroperoxyl H02• Hypochlorous acid HOCI 
Carbonate C03·' Ozone 0 3 
Peroxyl R02• Singlet oxygen 0 2
1 ~g 
Alkoxyl RO· Organic peroxides ROOH 
Carbon dioxide CO2.' Peroxynitrite ONOO' 
Peroxynitrate 02NOO' 
Peroxynitrous acid ONOOH 
Nitrosoperoxycarbonate ONOOC02' 
Peroxomonocarbonate HOOC02' 
In his final paper published in 1934, Professor Fritz Haber (with Joseph Weiss) was the first 
to propose that the interaction between superoxide and hydrogen peroxide could generate 
the highly reactive hydroxyl radical 130. It was quickly recognized that the Haber-Weiss 
reaction (Eq. 3) may be a mechanism to generate more toxic radicals. The basic reaction 
(Eq. 3) has a second order rate constant of zero in aqueous solutions and is thus 
thermodynamically unfavourable in biological systems. Transition metal ions, such as iron, 
are present at low concentrations in biological systems, and are able to act as catalysts for 
the reaction (Eq. 1 and 2), possibly accounting for the in vivo production of the hydroxyl 
radical. The iron-catalyzed Haber-Weiss reaction, which makes use of Fenton chemistry, is 
the principle pathway in generating the most reactive oxygen species, the hydroxyl radical, 











The net reaction: 
Following UV A-irradiation, the majority of hydrogen peroxide produced in cultured human 
keratinocytes appears to originate from superoxide, and its subsequent conversion to 
hydroxyl radicals appears to be a critical step in the UV A-induced generation of strand 
breaks and alkali-labile sites 131, 
1.6 Antioxidant Defense 
1.6.1 Redox Homeostasis 
ROS have been identified as both deleterious and beneficial molecules within living 
systems 126, At low or moderate concentrations, reactive species, such as nitric oxide and 
superoxide, function in the induction of mitogenic responses and in redox signalling, the 
latter of which is a regulatory process where the signal is delivered through redox 
chemistry I32, Studies have shown that the hydrogen peroxide produced by receptor binding 
of numerous peptide growth factors is required for certain signal transduction cascades, such 
as the signalling pathways involving insulin 133 and vascular epithelial growth factor 134, It 
has been further shown that the addition of certain antioxidants leads to a suppression of 
both survival and death signalling, indicating that both of these vital pathways are redox-
regulated 135, 
1.6.2 Antioxidants 
The redox system IS vital in maintaining cellular homeostasis, Under physiological 
conditions, redox regulation is achieved through the generation and elimination of ROS and 











a similar rate of their expenditure by enzymatic and non-enzymatic antioxidants (table 1.2). 
An antioxidant is 'any substance that delays, prevents or removes oxidative damage to a 
target molecule' 115. When the antioxidant defense mechanisms are overwhelmed by 
increasing ROS, the pro-oxidant/ antioxidant equilibrium is shifted in favour of the pro-
'd I"'d . 1,6 OXI ants, resu t1l1g 111 OXI atlve stress - . 
Table 1.2 Enzymatic and non-enzymatic antioxidants 
Enzymatic Non-enzymatic 
Superoxide dismutase (SOD) Ascorbic acid (vitamin C) 
Catalase (Cat) a-Tocopherol (vitamin E) 
Glutathione peroxidase (GPx) Glutathione (GSH) 
Glutathione reductase (GR) Ubiquinone/ ubiquinol (CoQ) 
Thioredoxin reductase (TR) Thioredoxin (Trx) 
Heme oxygenase 
1.6.2.1 Enzymatic Antioxidants 
A major enzymatic antioxidant, which is responsible for the dismutation of superoxide to 
hydrogen peroxide, is superoxide dismutase (SOD) (Eq. 4). Several isoforms of SOD inhabit 
various cellular compartments. SOD 1 (cytosolic or copper-zinc SOD- CuZnSOD) is the 
major isoform found in the cytoplasm, mitochondrial intermembrane space, nucleus and 
Iysosomes, whereas SOD2 (manganese SOD- MnSOD) and SOD3 (extracellular SOD- EC-
SOD) are found in the mitochondria and extracellular matrix respectively 137. Further 
conversion of H20 2 to H20 + O2 occurs through the action of catalase (Eq. 5) or through 
reduction by the seleno-enzyme glutathione peroxidase (GPx) (Eq. 6), whereby GPx 
catalyzes the oxidation of reduced glutathione (GSH to GSSG). The reduced form of 



















GSSG + NADPH + H+ ------')'J> 2GSH + NADP+ (7) 
Superoxide dismutase, catalase and the enzymatic glutathione system are all present in 
higher concentrations in the epidermis than the dermis, with catalase activity in particular 
being remarkably higher (720%) in the epidermis 138. The deleterious effect of UVA-
irradiation on keratinocytes is illustrated by the significant decrease in both SOD and 
catalase activity upon exposure 111. Like most cellular macromolecules these enzymatic 
antioxidants are susceptible to oxidative reactive species, and if the oxidative stress is great 
enough they may be completely inactivated, leading to a further increase in stress 139. The 
effects of UV A-treatment on dermal fibroblasts illustrate an inactivation of catalase and a 
reduction of SOD, with levels of GPx and GR remaining virtually unchanged 140. 
1.6.2.1.1 Heme Oxygenase and Iron 
In 1989, Keyse and Tyrrell determined that heme oxygenase (HO) was the major 32 kDa 
stress protein that was found to be induced in human skin fibroblasts by UV A-irradiation 141. 
It has since been identified that singlet oxygen is a primary effector in the induction of 
HO 142. HO-l is an inducible form of the enzyme, and is responsible for heme-catabolism, 
resulting in biliverdin, carbon monoxide and iron 143. Bilirubin (derived from biliverdin) has 
d · I . b'l" 144 145 146 147 h'l b 'd h b h strong ra Ica scavengmg capa I Itles . .. . ,w I e car on monoxl e as een sown 
to be involved in the photoimmunoprotective effect of UVA 148. 149, 150, 151. The UVA-
induced transcriptional activation of HO-I eventually (i.e. 1 to 2 days) leads to a HO-l 
dependent increase in the iron-storage protein ferritin 152 and a consequent lowering of the 
pro-oxidant state of the cells 153. However, there is an initial decrease in the amount of 
ferritin, before the increase 1 to 2 days later, due to UV A-induced proteolysis which 











that singlet oxygen and hydrogen peroxide generated by UV A promote biological damage 
such as lipid peroxidation in cultured human fibroblasts, via iron-catalyzed oxidative 
reactions 112. 15-1. 155. Human keratinocytes have higher basal levels of the non-inducible form 
of heme oxygenase (HO-2) than fibroblasts, but little inducible (HO-I) activity 115. The 
keratinocytes are the 'first line of defense' against UV A, and may require the added 
protection of constitutively expressed HO. 
Along with members of the heat shock protein and thioredoxin families, HO-I is considered 
a vitagene. The term 'vitagene' refers to a subset of genes that are involved in maintaining 
cellular homeostasis during stressful conditions, such as oxidative stress 156. Inducers of HO-
I include compounds such as phenolic antioxidants and Michael reaction acceptors, which 
act via a transcriptional enhancer element known as the antioxidant responsive element 
(ARE) 157. 158. 159. Phenolic antioxidants which have shown the ability to induce HO-I 
expression include curcumin (in neuronal cultures) and ferulic acid ethyl ester (in human 
fibroblasts) 156. 160. 
1.6.2.2 Non-Enzymatic Antioxidants 
1.6.2.2.1 Hydrophilic Antioxidants 
Endogenous non-enzymatic antioxidants (table 1.2), recognized to execute thiol-disulfide 
exchange reactions, playa major role in maintaining redox homeostasis. Glutathione (GSH), 
the most abundant peptide in cells, possesses a multitude of functions ranging from being a 
co-factor of various antioxidant enzymes, to directly scavenging hydroxyl radicals and 
singlet oxygen, and regenerating other antioxidants such as vitamins C and E to their active 
forms 161. Thioredoxin, a seleno-protein containing two redox-active cysteines, is an 
important thiol antioxidant making up the thioredoxin system, consisting of thioredoxin 
(Trx) and thioredoxin reductase (TR) 162. Didier et al. (2001) demonstrated an increase in 
intracellular levels of Trx and TR in UV A-irradiated human skin fibroblasts. They further 
showed that inducible Trx was able to decrease ROS production and protect against UV A-
. d d . 16'1 











Vitamin C is one of the body's major aqueous phase reductants 16-1. It is the predominant 
antioxidant in the skin, with its concentration being IS-fold more than GSH and 200-fold 
more than vitamin E 165. This essential water-soluble vitamin comprises two major 
intcrconvertible forms, L-ascorbic acid (figure 1.6) and L-dehydroascorbic acid, both 
present in biological tissues and food 166. Vitamin C does not absorb UVA and its quenching 
activity arises solely due to its capacity to scavenge reactive species such as hydroxyl 
d · I 'd d' I 115 167 B . d . f I h ra Ica s, superoxI e an smg et oxygen .. . y systematIc onatIOn 0 an e ectron, t e 
resulting ascorbate free radical formed is more stable than most other free radicals, hence its 
functional significance as a free radical chain terminator. After the loss of a second electron, 
dehydroascorbate can be regenerated to ascorbate by dehydroascorbic acid reductase or 
GSH (figure 1.7), or may simply decay 165. 
HO eli, 
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HO OH ell, 
Figure 1.6 Structure of L-ascorbic acid (left) and a-tocopherol (right). 
1.6.2.2.2 Hydrophobic Antioxidants 
Co-enzyme Q (CoQ) (ubiquinone and ubiquinol) is a lipid-soluble redox molecule that 
functions mainly as a component of membrane electron transport systems such as the 
mitochondrial respiratory chain 168. In the skin the majority of ubiquinone exists in its 
oxidised form ubiquinone-IO 169, which has been shown to protect primary and HaCaT 
keratinocytes against UV A-induced oxidative DNA damage, as well as reduce the 
detrimental photoaging effects of UV A on dermal fibroblasts 170. 
Vitamin E is an essential vitamin that, in humans, is rarely deficient due to its broad 











occurring compounds that exhibit vitamin E activity. These include four tocopherols (phytyl 
side chains) and four tocotrienols (isoprenoid side chains) 169. The a-, ~-, y- and 0-
tocopherols and tocotrienols, which each contain an essential hydroxyl group necessary for 
antioxidant activity, differ only in the number and position of the methyl groups on the 
chroman ring. The most potent isoform is RRR-a-tocophcrol (figure 1.6), which is 
responsible for about 90% of the vitamin E activity found within tissues 171. This lipophilic 
compound partitions into lipoproteins and cell membranes, where it can confer stability and 
function as a lipid antioxidant to protect the polyunsaturated membrane lipids from free 
radical attack. When ROS attack membrane lipids a peroxyl radical may form, which has the 
ability to generate more peroxyl radicals, which may propagate a chain reaction and threaten 
the structural integrity of the membrane 172. The propagation of these chain reactions may be 
inhibited through the peroxyl scavenging activity of a-tocopherol, which in addition is able 
to quench the highly reactive singlet oxygen 173. It has been determined that the 
concentration of a-tocopherols is 90% higher in the epidermal layer than the dermal layer in 
human skin 138, which is necessary considering tocopherols in the stratum corneum are 
highly susceptible to solar stimulated UV irradiation, and both a- and y-tocopherollevels are 
dramatically reduced following exposure to UVA and UVB 17-+. 
Non-enzymatic antioxidants work in tissues, including the skin, as a coordinated interactive 
group of compounds related to chemical structure, location and relative redox potential 175. 
For example, when a ROS is generated in a membrane structure and is reduced by a-
tocopherol, the oxidised antioxidant can be regenerated by ubiquinol or L-ascorbic acid. The 
resulting dehydroascorbate can be reduced by GSH, which can subsequently be reduced by 
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maintenance of cell wall shape and integrity, as well as protection against UVR and 
pathogens 183. 184. Polyphenols can be subdivided into various groups, including phenolic 
acids, tlavonoids, stilbenes and lignans, based on the number of phenol rings they possess 
and of the structural components that bind these rings together 185. Phenolic acids may be 
distinguished as derivatives of either benzoic or cinnamic acid. The hydroxycinnamic acids 
are more common than the hydroxybenzoic acids and consist mainly of the structurally 
related p-coumaric, caffeic, ferulic and sinapic acids, which are synthesized via the 
shikimate pathway from L-phenylalanine or L-tyrosine 185. 186 (figure 1.8). This class of 
phenylpropanoids have well characterized physiological activities, such as anti-cancer 187, 
. . fl . 187 . h .. 188 d . . d' 184. 189 antJ-1I1 ammatlOn ,antJ- epatoxlclty an antl-oxi atlOn . 
Phenylalanine Cinnamic Acid 
COOH COOH COOH COOH COOH 
NH, 
OH 
OH OH OH OH OH 
Tyrosine P-Coumaric Acid Caffeic Acid Ferulic Acid Sinapic Acid 
Figure 1.8 Biosynthesis of hyroxycinnamates via the shikimate pathway 186. 
The antioxidant activity of polyphenols may be anticipated based on the availability of the 
phenolic hydrogens as hydrogen-donating radical scavengers. For a polyphenol to be 
defined as an antioxidant, it must comply with two basic criteria: firstly, it must be able to 











concentration relative to the substrate being oxidised 115; and secondly, the ensuing radical 
formed post-scavenging must be stable through intramolecular hydrogen bonding upon 
further oxidation 190. 
1.7.2 Ferulic Acid and Related Compounds 
Hydroxycinnamates are found in all compartments of fruit, with the highest concentrations 
seen in the outer parts of ripe fruit. Caffeic acid, free and esterified, is typically the most 
profuse phenolic acid accounting for between 75 and 100% of the overall hydroxycinnamic 
acid content of most fruit 185, whilst ferulic acid (FA) is the most plentiful phenolic acid 
found in cereal grains, constituting approximately 0.8-2 g/kg (dry weight) of wheat grain 
and may represent 90% of the total polyphenols 191. FA has a distinctive bi-functional role in 
the structuring of cell walls in that it can cross-link heteroxylans in cereal tissues and pectins 
in beet root tissues 178. Apart from 10% that exists in the soluble free form, it is primarily 
found in the trans form, esterified to arabinoxylans and hemicelluloses 191. It may also exist 
as a dimer in certain cereals, forming bridge structures between hemicelluloses chains 185. 
The main mechanism for a phenolic antioxidant is the trapping and stabilizing of radical 
species such as the lipid peroxyl radical. The elucidation of the anti-oxidation mechanism of 
FA (3-hydroxy-4-methoxycinnamic acid) has been assessed kinetically 192 and by a 
structure-activity approach 193. It is widely accepted that its antioxidant potential may be 
attributed to its structural characteristics, as its phenolic nucleus and unsaturated side chain 
can readily form a resonance stabilized phenoxy radical 19-+. Any reactive species interacting 
with FA are highly capable of abstracting a hydrogen atom, forming a phenoxy radical. The 
resultant radical is highly stable as the unpaired electron may be positioned on the oxygen, 
or delocalized across the entire molecule. The phenoxy radical generated is unable to initiate 
or propagate a radical chain reaction and most likely will collide and condense with another 
ferulate radical to give rise to the dimer curcumin, itself a well reported radical 
scavenger 195. Such coupling may generate a variety of compounds, the majority of which 











Kanski et ai, (200 I) have demonstrated that FA is able to efficiently attenuate free radical 
damage in a neuronal cell line more effectively than structurally related vanilic, cinnamic 
and coumaric acids, through a decrease in ROS formation and lipid and protein 
oxidation 196, Ferulic acid has also been shown to reduce lipid peroxidation in 
, 197 d I' 198 199 d f'f" I "'d 198 lId' h I mlcrosomes an Iposomes ' an e IClent y scavenge mtnc OXI e ,,- Ip eny-
, 199 200 "01, , 1(P 2-plcrylhydrazyl (DPPH) , '~, superoxlde and hydroxyl radIcals - -, Importantly, FA 
appears to be a viable option for topical in vi\'O protection against UV A-induced skin 
damage as it readily permeates through the stratum corneum of excised human skin 198, A 
naturally occurring and more hydrophobic form of FA (ferulic acid ethyl ester) has been 
shown to protect against hydrogen peroxide- induced lipid and protein oxidation in human 
dermal fibroblasts 156, Despite these reports, the mechanism of how FA is able to confer 
protection in skin cells against UV A-mediated oxidative stress still remains to be elucidated, 
1.8 Antioxidant Combinations as Photoprotective Agents 
The rising incidence of both melanoma and NMSC, and the established role of solar UVR in 
the aetiology of photocarcinogenicity 203, provides evidence for an urgent need of an 
improved skin photoprotection system that provides adequate defense against both UV A and 
UVB 20-+, The incorporation of antioxidants into photoprotective agents is a feasible option 
for combating UV-mediated oxidative damage, Studies are currently being undertaken to 
isolate potential antioxidants and polyphenolic compounds that could be used to attenuate 
the deleterious effects of UV A on human skin 205, 
The complementary effects of combining vitamins and antioxidants are well established 165. 
"06 "07 "08 "09 "10 V' 'E' b'l' I' 'd I d' I d bIb ~ . ~ . ~ . ~ .• , Itamm s a I Ity to scavenge Ipl peroxy ra Ica san su sequent y e 
reduced by vitamin C to regenerate its active form 211 remains the key reason why this 
antioxidant pair is often incorporated into topical cosmeceutical formulations 212, It has been 
shown that a topical solution containing L-ascorbic acid (l59c) and a-tocopherol (l %) 
provides a four-fold photoprotective effect against UV-irradiation in porcine skin compared 
to a two-fold protection for either vitamin alone m, Interestingly the addition of FA (0,5%) 











the photoprotection from four to eight-fold 208. 20'1. In 2008, Murray et at. were able to 
reproduce this work on human skin, and confirmed that the combination was able to confer 
significant photoprotection against solar-simulated UV-radiation 210. 
Despite this ill vivo study, in vitro studies have not been undertaken to elucidate the effect of 
the FA with vitamins C and E (vEC) combination treatment on the specific cells of the 
epidermis and dermis. 
1.9 Cell Death Mechanisms 
1.9.1 Cell Death 
With continued UV A-induced oxidative insult, the primary defensive mechanisms employed 
by the cell are often not adequate to entirely avoid cellular damage and a second line of 
defense is required. In an attempt to survive persistent oxidative stress, cells may initiate the 
process of autophagy. Autophagy pathways, including macroautophagy, microautophagy 
and chaperone-mediated autophagy, are some of the early cellular responses to early-stage 
oxidative stress for removal of damaged components before further damage or aggregation 
occurs 214. 215. 216. 
1.9.2 Apoptosis 
In 1972 the concept of apoptosis emerged 217, and our knowledge of the mechanisms 
involved increased considerably through the study of programmed cell death that occurs 
throughout the development of the nematode Caenorhabditis elegans 218. This structured 
cell clearance system has distinct morphological features that are distinguishable from 
senescence or necrosis, such as cell shrinkage, plasma membrane blebbing, chromatin 
condensation, DNA fragmentation and the formation of apoptotic bodies 217 (table \.3). 
Cells undergoing apoptosis are renowned for displaying 'come and eat me' signals to 
neighbouring phagocytes, and one of these signals is phosphatidylserine (PS) externalisation 
of the cell membrane. These phospholipids usually exist on the cytoplasmic side of the cell 











apoptosis 219. 220, This translocation of PS ensures that the apoptotic bodies are swiftly and 
'I Ifdb h 'd' 'fl '17"0 07 1222 sale yengu e y p agocytes, avO! II1g an 111 ammatory response - . -- . -- . 
Table 1.3 Differences between apoptotic and necrotic cell death 223, 
Apoptosis Necrosis 
Individual cells/ small clusters of cells Neighbouring cells affected 
Cell shrinkage and convolution Cell swelling 
Pyknosis and karyorrhexis Karyolysis, pyknosis and karyorrhexis 
Intact cell membrane Disrupted cell membrane 
Cytoplasm contained in apoptotic bodies Cytoplasm released from cells 
No inflammatory response Inflammatory response 
It has been shown in skin reconstructed in vitro that UV A is able to induce apoptosis in the 
superficial dermal fibroblasts without major alterations to the epidermal keratinocytes 224, 
This effect suggests differential cell type sensitivity to UV A radiation, which is expected 
considering the epidermis is the first line of defense and needs to be well equipped to resist 
damage, Although it must be noted that keratinocytes are not completely resistant to the 
damaging effects of UV, and that FA vEC pre-treatment of both porcine and human skin has 
been shown to reduce the number of apoptotic keratinocytes (sunburn cells) compared to 
untreated skin upon exposure to solar-stimulated UV 208. 209. 210. 225, 
1.9.2.1 Caspases 
Some of the key proteins in apoptosis belong to a family of cysteine proteases know as the 
caspases, To date, approximately 14 mammalian caspases have been identified and broadly 
categorized as initiators (caspases-2, -8, -9, -10), executioners (caspases-3, -6, -7) and 
inflammatory caspases (-I, -4, -5) 223, Caspases-II, -12, -13 and -14 are involved in various 
h ' "6 '77 2
7 8 779 I ' , h ' d' ot er apoptotlc processes -- , --, -. --, I11tlator caspases ave a promll1ent pro- omall1, 
unlike the executioner caspases that contain either a death effector domain (DED) (caspases-
8, -10) or a caspase activation and recruitment domain (CARD) (caspase-2, -9) 230, 











leading to the many morphologic features of apoptotic cell death 231. Pre-treatment with the 
FA vEC combination has been demonstrated to protect against caspase-3 and -7 activation in 
. k' 208. 209 porcllle s 111 . 
1.9.2.2 Extrinsic Pathway of Apoptosis 
The process of apoptosis may be triggered by extrinsic (death-receptor mediated) or intrinsic 
(mitochondria mediated) switches (figure 1.10). The extrinsic signalling pathway involves 
transmembrane receptor-mediated interactions, specifically death receptors that are members 
of the tumour necrosis factor (TNF) receptor gene superfamily 232. Members of this family 
share similar features and are characterized by the presence of cysteine rich domains, that 
facilitate ligand binding, as well as a critically important 80 amino acid cytoplasmic domain, 
referred to as the 'death domain' 233. This death domain is vital in conveying the 
extracellular death signal to the intracellular signalling pathways. Two examples that best 
exemplify the extrinsic phase of apoptosis are that of the Fatty acid synthetase ligand 
(FasL)/ FasR and TNF-a/ TNFR I. The binding of Fas ligand to Fas receptor leads to 
recruitment of the cytoplasmic adaptor protein Fas-associated death domain (FADD), and 
the binding of TNF ligand to TNF receptor results in binding of the adaptor protein TNF 
receptor-associated death domain (TRADD) with additional recruitment of FADD and 
receptor-interacting protein (RIP) 234. 235. FADD subsequently associates with procaspase-8 
through dimerization of their individual death effector domains (DED), which effectively 
forms a death-inducing signalling complex (DISC) and leads to the autocatalytic activation 
of procaspase-8, which is capable of triggering a caspase cascade and subsequent cell death 
by directly cleaving downstream executioner caspases, such as caspase-3 and -7 236, 237. 
Death receptor-mediated apoptosis can be inhibited by a protein known as FLICE-inhibitory 
protein (c-FLIP) which binds to FADD and caspase-8, rendering them redundant 238. 
1.9.2.3 Intrinsic Pathway of Apoptosis 
The mitochondrial pathway is used extensively in response to extracellular cues and internal 
insults such as DNA damage 239 This pathway proceeds when pro-apoptotic factors 
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BH3-only proteins may be classified as de-repressors (e.g. Bad, Puma and Noxa) or direct 
activators (e.g. Bid and Bim). De-repressor BH3-only proteins bind anti-apoptotic BcI-2 
proteins and displace direct activator BH3-only members, thus promoting MOMP. De-
repressors themselves do not directly activate the effector proteins Bax and Bak. For 
example, Bid can be released from BcI-xL by Bad and go on to interact with the effector 
proteins Bax and Bak 243. 
Upon activation of the BcI-2 effector molecules Bax and Bak, they oligomerize to form 
homodimers that embed in the outer mitochondrial membrane to promote the release of 
intermembrane space molecules such as cytochrome c 242. Upon permeabilization these 
apoptogenic proteins, including second mitochondrial activator of caspases (Smac)1 direct 
lAP binding protein with low pI (DIABLO), Omi! high temperature requirement protein 2A 
(HtrA2), AIF, endonuclease G and cytochrome c, are expelled into the cytosol to elicit the 
. f II d h b 'b' I d d' "48 "49 . executIOn 0 ce eat y contn utmg to nuc ear egra atJon ~ . ~ , promotmg caspase 
activation or by acting as caspase-independent death effectors 250. A family of proteins 
capable of suppressing the caspase activity, the inhibitor of apoptosis proteins (lAPs), are 
negatively regulated by the apoptogenic factors SmaclDIABLO and Omi/Htra2A 251. When 
cytochrome c is released, it is able to bind to the C-terminal of the adaptor protein apoptotic 
protease activating factor (Apaf-l), which triggers a dATP-dependent oligomerization of 
Apaf-l, a process required for activation of the initiator caspase, caspase-9 252. Caspase-9 
contains a long pro-domain, which allows it to interact with the N-terminal CARD present 
on Apaf-l. The resultant complex formed is referred to as the apoptosome. Once activated, 
caspase-9 is free to activate executioner caspases such as caspase-3, -6 and -7, which 
subsequently affect target molecules such as inhibitor of caspase-3-activated DNase: 
caspase-3-activated DNase (ICAD: CAD) 253 (figure 1.10). 
Cross-talk and integration between the death-receptor and mitochondrial pathways is 
mediated via the pro-apoptotic Bcl-2 family member Bid. Bid is another substrate of 
activated caspase-8, and the C-terminal of the truncated form translocates to the 
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Another mode of cell death is necrosis, which is considered to be a noxious process where 
the cell passively follows an energy-independent mode of cell death 223. Although the 
process of apoptosis and necrosis appear to be two distinct pathways, they appear to overlap 
via morphologic expressions of a common biochemical network termed the 'apoptosis-
necrosis continuum' 256. An ongoing apoptotic process may be converted to a necrotic 
process if there is a diminished availability of caspases and intracellular ATP 257, 258. The 
nature of the cell death signal, the tissue type and physiological milieu are all factors that 
determine whether a cell dies by necrosis or apoptosis 256. 259, Some of the prominent 
morphological changes that materialize during necrosis include cell swelling, vacuolation, 
damage to organelles and ultimately loss of cell membrane integrity (table 1.3) 217. 260, 
It has been shown that the mode of UVA-induced cell death in human fibroblasts shifts from 
apoptosis to necrosis at high doses of UV A 159, whereas human keratinocytes are able to 
resist both modes of death 256, It is thought that cell-type specific susceptibility to UV A-
induced necrotic cell death in skin cells is directly correlative to the intracellular labile iron 
pool 261. The differential response of epidermal keratinocytes and dermal fibroblasts to UV A 
may partially be explained by the keratinocytes having a lower basal and UV A-inducible 
labile iron level than the fibroblasts 261. Also, unlike the fibroblasts, there is no significant 
decrease in UVA-mediated ATP depletion in keratinocytes 261, which is a hallmark of 
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Project Objective and Aims 
Objective 
The broad project objective is to elucidate the protective effects of ferulic acid, in 
combination with vitamins C and E, on UV A-irradiated human keratinocytes and 
fibroblasts. 
Aims 
Aim I: Determine the optimal concentration of ferulic acid for human keratinocytes (HaCaT 
cells) and human! mouse fibroblasts (primary human fibroblasts and murine 3T3 cells). 
Aim 2: Quantify the amount of ROS produced following UV A-irradiation and subsequently 
determine the lipid peroxidation status in human keratinocytes (HaCaT cells) and fibroblasts 
(primary human fibroblasts). 
Aim 3: To establish whether treatment was able to attenuate cell death, and if not, identify 
the mode of cell death in human keratinocytes (HaCaT cells) and fibroblasts (primary 
human fibroblasts). Proteins specific to the mode of cell death in fibroblasts would then be 
assessed. 
Hypothesis 
The pre-treatment of human epidermal keratinocytes and dermal fibroblasts with the 
antioxidant combination of ferulic acid, vitamin C and vitamin E will confer protection 
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Chapter 2: Materials and Methods 
2.1 Cell Culture 
2.1.1 General Maintenance 
A spontaneously transformed human keratinocyte cell line (HaCaT, a gift from Dr. N. 
Fusenig, Heidelberg, Germany) represented epidermal cells, while primary human dermal 
fibroblasts (courtesy of Ms. Ingrid Baumgarten, Department of Chemical Pathology, UCT) 
and an immortalized mouse embryonic fibroblast cell line (NIH13T3 cells, ATCC number 
CRLI 658) represented dermal cells in all experiments. (Murine 3T3s were initially 
incorporated into this study as the availability of primary human fibroblasts was uncertain. 
Human fibroblasts were the preferential dermal representative, and once they became 
frequently available the 3T3s were excluded from experiments.) 
All cells were aseptically maintained in Dulbecco's Modified Eagle's Medium (DMEM) 
(Highveld Biological Pty. Ltd., Johannesburg, South Africa), supplemented with 10% (v/v) 
heat inactivated Fetal Bovine Serum (Highveld Biological Pty. Ltd., Johannesburg, South 
Africa) and I % penicillin (100 U) (Sigma, Schnelldorf, Germany)/ streptomycin 
(l00 flg/ml) (Sigma, Schnelldorf, Germany), at 3TC in a humidified 5o/c CO2 atmosphere. 
Cells were checked daily for any morphological changes, and tested for mycoplasma 
contamination fortnightly (Appendix B). To passage cells, media was removed and cells 
were rinsed once with I X phosphate-buffered saline (IX PBS) (Appendix A), before being 
incubated in a trypsin (0.05%)/ ethylenediaminetetraacetic acid (EDTA) (0.02%) solution 
(Appendix A) for 5 min at 3TC. HaCaT cells received treatment with 0.05% EDT A 
(Appendix A) for 10 min at 3TC prior to trypsinization. All primary human fibroblasts used 











2.1.2 Phase Contrast Microscopy 
Cell were seeded onto coverslips (22x22 mm, Marienfeld, Lauda-Konigshofen, Germany) in 
35 mm" dishes, and grown until approximately 90% confluent. Cells were treated according 
to the experimental setup (Chapter 2, Subsection 2.2.2). Following irradiation complete 
DMEM was added and cells were allowed to recover for 30 min. Medium was removed and 
cells were rinsed with IX PBS before being placed in a 4IJc paraformaldehyde solution 
(Appendix A) for 15 min. The coverslips were rinsed with IX PBS and mounted onto a slide 
(Marienfeld, Lauda-Konigshofen, Germany) using mounting fluid (Appendix A). Slides 
were viewed on the Zeiss Axiovert 200M fluorescent microscope, and images were taken 
using a monochrome Zeiss high resolution camera (Axiocam HR). Images were analysed 
using Zeiss Axiovision software (version 4.8). 
2.2 Experimental Design 
2.2.1 Irradiation Conditions 
In all experiments cells were irradiated with 22.3 J/cm" UVA, provided by FI5WIT8 PUVA 
lamps (Waldmann, Germany), determined by the following formula (where I is a measure of 
irradiance and T is time): 
T (min) = Dose (mJ/cm2)/0.06 
I (~W/ cm2) 
The wavelength emitted was between 315-400 nm (UV A), with an emission maximum of 
365 nm. This formula was used to calculate the total time needed to deliver a dosage that 
was equivalent to 30 min in the midday South African sun. A time of 2 h 12 min, equivalent 











2.2.2 Experimental setup 
The standard experimental setup included all the following controls (figure 2.1): 
I. control (vehicle l only) 
II. control- sham2 (vehicle only) 
III. FA only- sham 
IV. FA + vEC3- sham 
V. FA + vEC +UVA 
VI. FA only + UVA 
VII. vEC only + UV A 
VIII. UVAonly 
L Vehicle was <1 % absolute ethanol for all samples 
2. Sham irradiation involved placing the experimental dishes under aluminium foil to prevent 
any resultant changes due to the UV exposure. 
3. 35 )1M Vitamin E (1 % (v/v)) and 50 )1M Vitamin C (10% (v/v)) (Appendix A) were used 
in all experiments. 
The treatment regime is summarised in figure 2.1. Briefly all cells were incubated with the 
various treatments for 18 h at 3TC in a 5% CO2 atmosphere, before being rinsed once with 
IX PBS and exposed to UVA. Cells were either harvested immediately or allowed to 
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fibroblasts; 2.5x I O~ cells/ well for 3T3 cells; and 5x 1O~ cells/ well for HaCaT cells. Cell 
numbers were determined through manual counting by means of a haemocytometer 
(Neubauer improved bright-line, Marienfeld, Lauda-Konigshofcn, Germany) (Appendix B) 
and allowed to adhere to the wells for 24 h. 
2.3.2 Determining the Optimal Concentration of FA 
To determine the optimal concentration of FA (Appendix A for stock solution) that 
generated the least amount of cytotoxicity, cells were treated with the following 
concentrations: 0.2 mM, 0.4 mM, 0.8 mM, 1.5 mM or 3 mM in complete medium. The final 
volume in all wells was 200 Ill, and cells were incubated for 18 h at 3TC in a 5% CO2 
atmosphere. The XTT reagent was prepared (Appendix A) and 50 III was added directly to 
each well and incubated for 4 h at 3TC. Following incubation the absorbance was measured 
at 450 nm using a multi-well reader (VERSAmax 1M tunable microplate reader, Molecular 
Devices, Sunnyvale, CA, USA; Software: Softmax Pro version 4.3.1) and results were 
calculated by determining the percentage viability relative to the control (vehicle only). 
2.3.3 Cell Viability Following UV A exposure 
To determine the effects of the various treatments on cell viability, cells were allowed to 
adhere for 24 h, before being exposed to treatment. Cells were incubated with the various 
treatments for 18 h at 3TC before being exposed to 22.3 J/cm2 UV A. Post-irradiation cells 
were incubated with XTT reagent for 4 h at 3TC. The absorbance was then measured at 
450 nm using a multi-well reader and results were calculated by determining the percentage 
viability relative to the control (vehicle only). 
2.4 Flow Cytometry 
Flow cytometry, which made use of a fluorescence-activated cell sorting (FACS) system, 
was used to quantify intracellular ROS and to determine the mode of cell death. The 
instrument used for this study was the Becton Dickinson FACS Calibur (Division of 











suspended in a narrow stream of fluid and passed through one or more laser beams that 
cause light to scatter and fluorescent dyes to emit light at different frequencies. Briefly, this 
system identifies cells by analysing forward and side scatter while fluorescent labelling is 
used to investigate cell structure and function. Fluorescence signals are accumulated in one 
to several channels relating to different laser excitation and fluorescence emission 
wavelength. In this study, forward and side scatter were measured in linear mode, while the 
fluorescent channels were measured using a logarithmic amplification scale. Green emitted 
fluorescence (Dihydrorhodamine 123 and Annexin V -FITC) was measured in fluorescence 
channel FLl (530 nm), while red emitted fluorescence (propidium iodide) was measured 
in fluorescence channel FL3 (675 nm). All data generated were analysed using Cell Quest 
Pro software (version 5.2.1). 
2.4.1 ROS Assay 
In order to quantify the amount of intracellular ROS produced, Dihydrorhodamine 123 
(DHR 123) (Molecular Probes®, Eugene, OR, USA) (Appendix A for stock solution), a 
fluorogenic substrate, which becomes oxidised from non-fluorescent, uncharged DHR 123 
to fluorescent, cationic rhodamine 123, was used. 
Cells were seeded onto 35 mm2 dishes and allowed to adhere overnight. Medium was 
changed every alternate day until the cells reached 90% confluence. Cells were then exposed 
to treatment according to the experimental treatment regime (Chapter 2, subsection 2.2.2), to 
a final volume of 2 ml. Following irradiation, 1 ml of fresh complete medium containing 
DHR 123 (0.1 mg/ml) was added to each dish, and cells were incubated for 30 min at 3TC. 
After the incubation period, media was collected and any non-adherent cells were harvested 
through centrifugation at 2500 rpm for 5 min (HermIe Z233 MK-2, HERMLE Labortechnik 
GmbH, Wehingen, Germany) at room temperature. The adherent cells were washed once 
with IX PBS, removed by trypsinization and pooled with the non-adherent cells. Eppendorf 
tubes containing entire cell populations were centrifuged at 3500 rpm for 5 min at room 
temperature, the supernatants discarded and the cells washed once with I X PBS. Cells were 
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2.5 Lipid Per oxidation Analyses 
2.5.1 Cell Preparation 
Cells were seeded in 100 mm2 dishes and grown to approximately 90% confluence. 
Treatment was added according to the experimental setup (Chapter 2, subsection 2.2.2). 
Cells were collected immediately following irradiation, by centrifuging any suspended cells 
at 2500 rpm for 5 min at room temperature, and by directly scraping cells from the dishes 
using a rubber policeman. Cells were then re-suspended in 1 ml 1 X PBS placed into a 50 ml 
falcon tube on ice and sonicated (MSE Soniprep ISO, Wolf Laboratories Limited, 
Pocklington, York, UK) for two 15 sec pulses at 12 amplitude microns. 
2.5.2 Folch Extraction 
Lipids were extracted from sonicated cells according to the Folch extraction protocol 263. 
Briefly, methanol (2500 Ill) was added to 1 ml of sonicated cells (in IX PBS) and vortexed 
for 10 sec, followed by the addition of 1250 III of chloroform. The mixture was vortexed for 
10 sec and centrifuged at 3000 rpm for 15 min (Eppendorf Centrifuge 58 lOR, Hamburg, 
Germany). The supernatant was transferred to a new borosilicate glass tube (Kimble/ 
Kontes, Vineland, NJ, USA), lipids were re-extracted from the remaining cell pellet and the 
supernatants combined. AI: 1 ratio of 0.9% saline (Appendix A) was added to the 
chloroform, mixed by inversion, and centrifuged at 3000 rpm for 15 min. The infranate was 
transferred, using a drawn-out pipette, to a new borosilicate tube before being dried down by 
nitrogen gassing (approximately 45 min). The borosilicate tube used in the final step was 
weighed before and after the lipid had been added, in order to determine the percentage of 
lipid peroxides relative to the total amount of lipid. 
2.5.3 TBARS Assay 
The TBARS assay was performed according to Asakawa and Matsushita (1980) 264. Briefly, 
dried lipids were re-suspended in 25 III of chloroform, while water and chloroform were 
used as controls. To 25 III of sample, 25 III FeCh (0.27%) (Appendix A), 25 III of butylated 











glycine.HCI) (Appendix A) and 375 fll thiobarbituric acid (TBA) (Appendix A) was added, 
vortexed vigorously and heated at 100°C for 20 min. After heating, 250 ~t1 glacial acetic acid 
was added, followed by 500 fll chloroform. Samples were vortexed vigorously and 
centrifuged at 3000 rpm for 15 min. The supernatant (300 fll) was placed in duplicate in a 
96-well plate and absorbance was measured at 532 nm. 
The molar extinction co-efficient for 300 fll supernatant (lAO X 105M· 1 .cm"l) was used to 
calculate the amount of TBARS per total lipid (flmol/mg) using the following formula 
(where A is absorbance): 
A532-blank ..;. lipid (mg) 
0.14 (flmol) 
2.5.4 Conjugated Diene Assay 
Samples were prepared as above (sections 5.2.1 and 5.2.2). Dried lipids were re-suspended 
in 1 ml cyclohexane and vortexed for 1 min. Samples (300 fll) were placed in triplicate in a 
96-well plate and absorbance was measured at 234 nm. 
The molar extinction co-efficient for 1 ml of cyclohexane (2.95 X 104M"I.cm"l) was used to 
calculate the amount of conjugated dienes per total lipid (flmol/mg) using the following 
formula (where A is absorbance): 












2.6 Protein Expression 
2.6.1 Cell Preparation 
Cells were seeded in 100 mm 2 dishes and grown to approximately 90% confluence. 
Treatment was added according to the experimental setup, and cells were allowed to recover 
for the stipulated time points (Chapter 2, subsection 2.2.2). 
2.6.2 Protein Extraction 
At the specified times (Chapter 2, subsection 2.2.2) dishes were washed twice with cold 
IX PBS and lysed in 150 fll cold complete RIPA extraction buffer (Appendix A). In all 
cases cells that had lifted during treatment were collected (by centrifugation at 2500 rpm for 
5 min at room temperature) and pooled with their respective dishes. Cell lysates were 
collected and placed at -80°C for 1 h to decrease DNA contamination. Samples were 
centrifuged at 12000 rpm for 20 min at 4°C. The supernatant was divided into two aliquots 
(to minimise freeze/ thawing) and were stored at -80°C until use. For the duration of the 
experiments samples were freeze/ thawed a maximum of three times each. 
2.6.3 Protein Quantification 
Total protein was quantified using the BCA Protein Assay kit (Thermo Scientific, Pierce, 
Rockford, IL, USA). This kit is based on the purple-coloured, water-soluble reaction product 
that is generated by the chelation of two bicinchonicic acid (BCA) with one cuprous ion. 
The protein concentrations are determined by measuring absorbance at 562 nm and plotting 
the unknown values against a standard curve generated by known concentrations. 
Fresh protein standards were prepared for all protein quantifications. A bovine serum 
albumin (BSA) working stock (2 mg/ml) was made up in 0.9% saline (Appendix A) and 
placed in duplicate in a 96-well plate on ice, representing standards concentrations of 0-
2000 flg/ml. These readings would later be used to generate a standard curve from which the 
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To quantify the extracted protein, 5 ~l of sample was placed in duplicate in a 96-well plate 
on ice. Samples were diluted 5X by adding 20 ~l of incomplete RIPA reagent. Working 
reagent was prepared (Appendix A) and 200 ~l was added to each well, followed by 30 min 
incubation at 3Te. Following incubation, absorbance was measured at 562 nm using a 
multi well-plate reader. The absorbance values were then read off the standard curve, 
generated from the BSA standard readings, to obtain accurate protein concentrations 
reported as ~g/ml. 
2.6.4 Western Blotting 
For western blot analyses, quantified samples were prepared for sodium-dodecyl-sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). A l59c resolving layer was overlaid with 
a 5% stacking layer (Appendix A), in an Enduro Vertical Electrophoresis System (Labnet, 
Labnet International, Inc., Woodbridge, NJ, USA). Protein samples were diluted to a final 
concentration of 40 ~g using incomplete RIP A buffer. Loading dye (Appendix A) was added 
(5 ~l) and samples were denatured for 2 min at 100°e. Five micro litres of protein marker 
(peqGOLD protein marker IV, PEQLAB Biotechnologie GmbH, Erlangen, Germany) was 
loaded into the first well to serve as a molecular weight control and approximately 25 ~l of 
sample was loaded into individual wells before the apparatus was submerged in fresh tank 
buffer (Appendix A). Proteins were electrophoresed at 80-100 V. 
Following electrophoresis, proteins were transferred to a nitrocellulose membrane 
(Amersham Hybond-ECL, GE Healthcare) at 100 V for 1 h in fresh, cold transfer buffer 
(Appendix A). Membranes were then briefly washed in TBS-T (Appendix A), before being 
blocked in 5% fat-free milk (Appendix A) for 1 h at room temperature. Membranes were 
subsequently incubated with primary antibodies overnight at 4°e. Table 2.1 lists the 
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Table 2.1 Concentrations of primary and secondary antibodies used in this study. 
Primary antibody Concentration Secondary antibody Concentration 
BC\-2 (Cat: Bcl-2 (100): Goat anti-mouse 
sc-509 mouse (Horseradish peroxidase 
1 :200 in 5% fat- 1:1500in5% 
monoclonal, Santa Cruz conjugated Cat: 170-
free milk fat-free milk 
Biotechnology, Inc., 6516, Bio-Rad, 
Santa Cruz, CA, USA) Hercules, CA, USA) 
Bax (Cat: Bax (B-9): Goat anti-mouse 
sc-7480 mouse (Horseradish peroxidase 
1 :200 in 5% fat- 1:1500 in 5% 
monoclonal, Santa Cruz conjugated Cat: 170-
free milk fat-free milk 
Biotechnology, Inc., 6516, Bio-Rad, 
Santa Cruz, CA, USA) Hercules, CA, USA) 
Goat anti-rabbit 
p38 (Cat: p-38 MAP 
(Horseradish peroxidase 
Kinase: M0800 rabbit 1 :5000 in 5% 
1 :5000 in TBS-T conjugated Cat: 170-
polyc\onal, Sigma, fat-free milk 
6515, Bio-Rad, 
Schnelldorf, Germany) 
Hercules, CA, USA) 
Following overnight incubation, membranes were washed twice for 10 mm m TBS-T, 
before being incubated with their respective secondary antibody in 5% fat-free milk for 1 h 
at room temperature. Membranes were rinsed twice for 10 min in TBS-T, prior to the 
addition of the chemiluminescent substrate (SuperSignal® West Pico Chemiluminescent 
Substrate, Thermo Scientific) for 1 min, and then exposed to medical x-ray film (CP-BU 
new film, AGFA) for various exposure times. Films were developed (AGFA Developer) 
(Appendix A) and fixed (Ilford Rapid Fixer) (Appendix A), for 2 min each, before being 
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2.6.5 Densitometry 
To quantify protein expression, densitometric analysis (semi-quantitative) was performed by 
scanning films into the computer (CanonScan 8000F), and utilising functions in the Image J 
software program (version 1.42q). Values obtained for each lane were divided by the protein 
loading control (p38) in order to standardise results. 
2.7 Data Analysis 
Data are shown as means ± SO. Differences between test and control conditions were 
assessed by performing unpaired, two-tailed t -Tests (Microsoft Office Excel 2007) and 
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Chapter 3: Results and Discussion 
The results presented in this chapter are aligned with the aims stipulated in Chapter I. The 
first aim was to determine the optimal concentration of FA for keratinocytes and fibroblasts. 
Once this was established, the effect of the FA vEC combination on UVA-induced ROS and 
the resulting consequence on lipid peroxidation was investigated. The next aim examined 
whether the FA vEC combination could protect UV A-exposed cells from cell death, and if 
not determine the mode of cell death employed. Once the mode of cell death was specified, 
the expression of related proteins was examined. The table below illustrates how the cell 
types will be represented throughout Chapter 3 (table 3.1). 
Table 3.1 Representation of cell types throughout this study. 
Cell Type Name Seen in Text Colour Representation 
Human keratinocytes HaCaTs BllIt' 
Primary human dermal fibroblasts HFbs Purpk 
Murine fibroblasts 3T3s 
3.1 Aim 1 
3.1.1 Determining the Optimal Concentration of FA 
The first aim was to identify the optimal concentration of FA for human keratinocytes 
(HaCaT cells) and human/ mouse fibroblasts (primary human dermal fibroblasts and 3T3 
cells). This was determined through the use of a cell viability assay (Chapter 2, subsection 
2.3.2). 
The addition of FA to HaCaTs resulted in a significant dose-dependent increase from 100% 
viability (vehicle only) to 179.77±32.13o/c with the addition of 3 mM FA (p<0.05) 
(figure 3.1). The doubling time of normal HaCaTs has been shown to be 42 h 265, and as the 
XTT assay measures viability over a total of 24 h, this increase may be explained by either i) 
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of 0.1 mM vitamin C 272. The addition of 0.8 mM FA to both 3T3 and human fibroblasts 
resulted in no significant decrease in cell viability, and thus, in keeping with the HaCaTs, 
0.8 mM was selected as a standard concentration for all future experiments. 
Whilst 0.8 mM FA proved the optimal concentration for this study (figure 3.1), FA 
concentrations utilised in other studies range widely. Trombino et al. (2004) illustrated that 
low concentrations of FA (0-50 flM) exhibited a wide range of antioxidant activities in 3T3 
cells and microsomal membranes 197, whilst other studies have shown the concentrations of 
FA required for 50% inhibition (lCso) of the DPPH radical, superoxide and hydroxyl 
radicals in solution are approximately 45.3 flM, 5312.3 flM and 502.1 flM respectively 202. 
For the purposes of this study, FA was to be used in combination with vitamins C and E, 
although the mechanism of FA's stabilizing effect on these vitamins remains unknown 209. 
What is known, is that the redox potential of FA is considerably higher than vitamins C and 
E (0.595 vs. 0.282 and 0.48 respectively) 273 and it is not believed to directly protect them, 
but to preferentially interact with pro-oxidative intermediates or serve as a sacrificial 
substrate 209. These studies lend further support to the use of 0.8 mM FA, the maximum 
concentration with the minimum amount of damage. 
3.1.2 Effect of Treatment on Cell Morphology 
To determine if the various treatments were having an effect on cell morphology, both 
HaCaTs and HFbs were studied 30 min post irradiation by phase contrast microscopy. In the 
HaCaTs there was little notable difference between control, FA vEC treated and UV-only 
cells (figure 3.2). The HaCaTs maintained their characteristic polyhedral shape 274, and did 
not display any noticeable form of cell surface blebbing or shrinkage at low and higher 
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Figure -'.2 Plla.c contra,t lllMgC' dcplCt1Tlg the morphological ~h<lng,,' lrl<lll~cd by eVA 
r",hati(}n. HaCaT, and HFb, 30 min poi-t-UVA ,rradiatlOn (rnmn Image: lOx, 'calc bar: 
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In this study, exposure of HaCaTs to 22.3 J/cm2 UVA led to a significant increase in the 
amount of intracellular ROS compared to the control (UV-only: 19.01±7.79 vs. Control: 
6.33±1.SS, p<0.05) (figure 3.4). This result correlates to work performed by 
Shorrocks et al. (2007), who demonstrated that high doses of UV A (1000 and 2000 J/cm2) 
was able to generate an increase in intracellular ROS in HaCaTs 83. The apparent reduction 
in ROS observed in HaCaTs pre-treated with the FA vEC combination appears to be solely 
due to the antioxidant activities of the vitamins. This finding correlates with work done by 
Pinnell et al. (2003) who showed that while the individual vitamins were able to confer 
photoprotection, the combination was far superior 213. They reported the combination of 
vitamin C (15%) and vitamin E (1%) was able to decrease sunburn cell formation (apoptotic 
keratinocytes), and provide a four-fold photoprotective effect, in porcine skin exposed to 
solar-stimulated radiation 213. However, Pinnell et al. (2004, 2005) showed the addition of 
0.59'c FA to their vEC solution was able to double the photoprotective effect 208. 209, which is 
not the effect observed in this in vitro study (figure 3.4). Although FA displays radical 
scavenging effects in antioxidant assay systems, where it is able to efficiently scavenge 
DPPH 199. 200. 201, superoxide and hydroxyl radicals 202, it appeared to have no effect on 
intracellular ROS levels in HaCaTs, compared to UV -only cells. This may be explained by 
FA reacting differently in HaCaT cells compared to in vivo 208. 209 or antioxidant assay 
systems 200. 202. 
In HFbs, 22.3 J/cm2 UVA appeared to lead to an increase in intracellular ROS in UV-only 
cells compared to control cells (UV-only: 6S.S2±59.S9 vs. Control: 27.39±7.0S) (figure 3.4). 
This observation was in accordance with a previous study by Polte and Tyrrell (2004) that 
showed the high UV A dose of 2500 J/cm2 led to an increase in intracellular peroxides in 
human dermal fibroblasts 113. Whilst the dose used by Polte and Tyrrell (2004) was 
exceptionally high, a lower dose of 10 J/cm2 UV A has also been shown to adversely affect 
human dermal fibroblasts by increasing singlet oxygen 276. Oplander et al. (200S) further 
demonstrated that whilst exposure to 25 J/cm2 UV A was able to increase intracellular 
superoxide in primary human dermal fibroblasts, the addition of 1 mM vitamin C was able 
to completely abrogate this effect 277. The present study examined the effect of 22.3 J/cm2 
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exposure to UV A 278. They also showed that phenol red acts as an UV A absorber rather than 
a photosensitizer, and this is also not optimal in irradiation experiments 278. In conclusion, 
simple buffers such as PBS are ideal solutions for irradiation experiments, provided 
irradiation time is kept to a minimum. 
3.2.2 Effects on Lipid Peroxidation 
The generation of UV A-induced ROS in skin cells is well documented 83. 276. 277. Reactive 
oxygen species produced as a result of UV A exposure results in an increase in lipid 
peroxidation in both human keratinocytes 83. 111 and fibroblasts 65. 112. To study the effect of 
the FA vEC antioxidant combination on lipid peroxidation in HaCaTs and HFbs, levels of 
conjugated dienes and TBARS were assayed for, being indicators of mid and late stage 
peroxidation respectively (Chapter 1, figure 1.4). 
In this study we found a negligible change in the levels of diene conjugation in HaCaTs 
exposed to 22.3 J!cm2 UV A (UV -only vs. control, figure 3.5). These findings were similar to 
those established by Punnonen et al. (1991), who showed that when human keratinocytes 
were exposed to 2.5 and 15 J/cm2 UV A there was little change in the amount of conjugated 
dienes 111. Interestingly, in our study the trend observed in conjugated diene levels 
throughout all the treatment groups follows the trend established in the ROS assay 
(figure 3.4). Furthermore it is evident that pre-treatment of HaCaTs with vEC leads to a 
substantial decrease in the amount of conjugated dienes compared to UV -only cells (vEC: 
1.09±O.03 Ilmol/mg lipid vs. UV -only: 1.77±O.66 Ilmol/mg lipid) (figure 3.5), which was in 
agreement with the effect of vEC pre-treatment on UVA-induced ROS production 
(figure 3.4). This illustrates that the vitamins may be protecting against increasing ROS 
levels, and subsequent lipid peroxidation. However, their involvement in the lipid 
peroxidation process still remains to be determined, as the TBARS assay showed the 
vitamins had little effect on the on the level of TBARS (figure 3.5). This was in contrast to 
the effect of FA on TBARS levels, which appeared to exacerbate the harmful effect of UV A 
(FA: 2.39±2.62 Ilmollmg lipid vs. UV-only: O.84±O.34 Ilmol/mg lipid). This detrimental 
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vEC compared to control cells (vEC: 2.7±0.07 ~lInollmg lipid vs. Control: I flmollmg lipid, 
p<0.05) (figure 3.6). This finding was in direct contrast to the effect of the vitamins in 
HaCaTs (Figure 3.5), indicating that the effects of antioxidant pre-treatment is cell type 
specific. Further lipid peroxidation analysis in both HaCaTs and HFbs is required to 
determine definitive results. 
In previous studies, FA has been shown to lower the amount of conjugated dienes and 
reduce MDA formation induced by the pro-oxidants 2,2' -Azobis-(2-amidinopropane) 
(AAPH) and tert-butyl hydroperoxide (tert-BOOH) in rat liver microsomal membranes 197. 
Although the conjugated diene and TBARS assays have been successfully employed in 
some studies looking at UV -induced lipid peroxidation in human keratinocytes and 
fibroblasts 65. Ill. 112, these assays are more suitable for systems where large amounts of 
lipids are being analysed. The amount of total lipid obtained from a near confluent 10 cm2 
dish, which ranged between 0.2 and 2 mg (data not shown), was insufficient to provide a 
feasible trend in this particular study. This was most likely due to lipid lost during the 
extraction procedure. An alternate approach could be to detect lipid peroxidation end-
products such as MDA by a more sensitive detection method such as high-performance 
liquid chromatography (HPLC) 197. Shorrocks et al. (2007) made use of a colourimetric kit 
that reacted directly with lipid peroxidation end products MDA and 4-HNE 83 while 
Calabrese et al. (2008), who studied the effect of a naturally occurring ester of FA (ferulic 
acid ethyl ester) on lipid peroxidation in human dermal fibroblasts, analysed levels of 4-
HNE by western blot analysis 156. What these highlight is that there is no 'gold standard' 
method for measuring lipid peroxidation and for any study a combination of techniques 
would be needed to yield conclusive results. 
Whilst ability of FA to inhibit lipid peroxidation is well documented 197. 198. 199.280, the exact 
mechanism of action has yet to be elucidated. Castelluccio et al. (1996) examined whether 
FA exhibited its antioxidant activity from the aqueous or lipophilic phase by studying the 
preferential cellular localisation of a radiolabelled form of FA 280. The majority associated 











density lipoprotein (LDL) and the aqueous phase. The FA isolated from the LDL-partic\e 
was shown not to associate with the lipid portion, indicating that FA exerts its antioxidant 
activity from the aqueous phase 280. Trombino et al. (2004) demonstrated that whilst the 
combination of FA and vitamin C interact syncrgistically, the combination of FA and a-
tocopherol appear to act antagonistically with regards to lipid peroxidation 197. The 
combination of FA with vitamin C strongly inhibited MDA formation in rat liver 
microsomal membranes, as detected by HPLC. This combination was highly efficient and 
displayed activity at low concentrations of 5 ~M for both antioxidants. Moreover, it was 
shown that while vitamin C protected FA from AAPH-induced depletion, vitamin E 
enhanced it 197. Despite this discrepancy, the synergistic interaction between 15% vitamin C 
and I % vitamin E has been shown to have a photoprotective effect against solar-stimulated 
radiation in porcine skin 213, and was further shown to be enhanced through the addition of 
0.5% FA 208. 209 . This may be due to FA acting as a sacrificial substrate, or perhaps the 
amount of vitamin C is sufficient to simultaneously reduce the rate of FA consumption and 
recycle vitamin E. Although FA is able to absorb UV radiation 192, and this absorption is 
theoretically able to provide a sunscreen effect, work performed by Pinnell et al. (2005) 
shows that increasing the volume of antioxidant solution during treatment demonstrated no 
dose-response effect to support the sunscreen mechanism 209. It is most likely having a 
photoprotective effect through its antioxidant activity. 
3.3 Aim 3 
The third aim of this study was to firstly establish whether pre-treatment could protect 
against cell death, and if not, determine the mode of death employed by human 
keratinocytes (HaCaTs) and fibroblasts (primary human dermal fibroblasts). Proteins 
specific to the mode of cell death in the HFbs would then be assessed by western blot 
analysis. 
3.3.1 Effect of Treatments on Cell Viability 
Zhong et al. (2004) found that HaCaTs exposed to 2500 and 5000 J/cm2 UVA were 
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UV-only cells; however, although cells treated with the FA vEC combination did not have a 
significantly larger viable population compared to UV -only, the combination pre-treatment 
was able to maintain a viable population comparable to that of control cells (FA vEC: 
77.4±40.87% vs. Control: 100%) (figure 3.7). This result was in agreement with the data 
obtained in this study pertaining to UV A-induced ROS (figure 3.4), suggesting that in HFbs 
the reduction of intracellular ROS may protect against cell death. This conservation of cell 
viability was in line with previous studies performed on human fibroblasts transiently 
transfected with inducible thioredoxin 163. These cells were subjected to the MTT cell 
viability assay, and showed that thioredoxin was able to decrease intracellular ROS levels 
(at 10 J/cm2 UV A) and fully protect the cells from a decrease in viability (12 J/cm2 
UV A) 163. These findings are encouraging, suggesting the possibility of supplementary 
antioxidants as feasible adjuvant photoprotective agents. 
Unlike the protective effect demonstrated in HFbs, pre-treatment with FA vEC did not 
protect against cell death in the HaCaTs and 3T3s, illustrating that cellular response to 
treatment and UV exposure is cell type/ species specific. Keratinocytes are the most 
superficial cells of the human body, and are the first line of defence against environmental 
stressors such as UV A (Chapter I, subsection 1.1.1). Bernerd et al. (1998) illustrated that 
UVA effects are targeted to the dermis 224. They studied the effect of 25 and 30 J/cm2 UVA 
on in vitro reconstructed skin. Regarding the induction of cell death, the keratinocytes were 
not affected by UV A, while the superficial dermal fibroblasts (obtained from a 16 yr old 
breast tissue donor) were drastically altered, suggesting a differential cell type sensitivity to 
UV A radiation 224. Numerous studies concerned with the UV A-induced oxidative stress 
response have determined that fibroblasts offered less resistance than keratinocytes 281. 282. 
In addition, keratinocytes express constitutively high levels of heme oxygenase-2 and 
i' .. "81 "83 h' hI' I . h d i' 'd . IS" d lernt1l1 - . - -,w IC p ay a VIta part 111 t e elence response to OXI atIve stress - an may 
confer additional resistance to keratinocytes exposed to UV A. Furthermore, 
Zhong et al. (2004) demonstrated that the high levels of resistance against UV A-induced 
damage in human keratinocytes, including HaCaTs, may be due to low basal and UV A-
inducible levels of labile iron 261. They showed the free and UV A-induced labile iron pool in 
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Two hours post-irradiation, HaCaTs pre-treated with FA alone or in combination with vEC 
had a significantly larger viable population than the control group (FA: 64.55±3.3% and 
FA vEC: 61.34±3.75% vs. Control: 44.25±5.969'c, p<O.05) (figure 3.9). There was no 
difference between any of the early apoptotic populations between groups, however FA vEC 
pre-treated and UV-only cells had significantly larger populations of cells undergoing late 
apoptosis compared to control cells (FA vEC: 25.69±3.987c and UV-only: 26.82±1.71 % vs. 
Control: 19.6±2.52%, p<O.05). The necrotic population of all UV -exposed cells was 
significantly smaller, than that of the control cells (UV -only: IO.39±3.99% vs. Control: 
38.42±3.957c, p<O.05). The fact that the control HaCaTs, which are vehicle-only, sham 
irradiated cells, have a larger necrotic population than all UV -exposed groups may be due to 
the lengthy 2 h 12 min irradiation time. As indicated previously (Chapter 3, 
subsection 3.2.1) this is a long time for cells to be incubated in PBS. Although not addressed 
in this study, a suggestion to reduce irradiation time would relate to increasing the spectral 
power output, which would require a more powerful UV -emitting device than the one 
utilised in this study. 
Despite all UV -exposed HaCaTs having a significantly smaller necrotic population than the 
control cells 2 h post-irradiation, at 4 h there was no variation in the any of the populations 
across all groups (figure 3.9). The protective effect of vEC in the HaCaTs that was 
previously observed to lower UVA-induced ROS (figure 3.4) and the amount of diene 
conjugation (figure 3.5) did not appear to have an effect on cell viability 4 h post-irradiation 
(figure 3.9).This indicates that the vEC may confer protection early on following UVA 
exposure, as ROS and conjugated diene are detected immediately post-irradiation. If the 
cells are continuously subjected to oxidative stress the vitamins may be depleted and cells 
may eventually die. The percentage of viable cells at the 4 h time point correlated to the 
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the viable population of the UV-only cells remained at a constant approximate 50%. The 
increase in the viable population of HaCaTs is interesting as their doubling time is 
approximately 42 h 265, yet the increase takes place within 24 h. One possibility that could 
explain this phenomenon may be that exposure to UV A may drive some cells into cell cycle 
arrest, as ROS are known to affect the cell cycle 284. Whilst high doses of UVA (1500 J/cm2) 
have been shown to have little effect on cell cycle progression 285, it can not be ruled out that 
a lower UVA dose (i.e. 22.3 J/cm2) will have the same outcome. Treatment with FA or vEC, 
alone or in combination, did not affect cell viability from 2- 24 h. These data show the 
antioxidant treatments have no effect on cell viability, in accordance with the XTT cell 
viability data (figure 3.7), and the mode of cell death across 2- 24 h post-irradiation in 
human keratinocytes appears to be predominantly via apoptosis. Interestingly these results 
are in contrast to previous studies that have demonstrated the FA vEC combination is able to 
effectively reduce the number of sunburn cells (apoptotic keratinocytes) in porcine and 
h k· "08 "09 olD 2°S 286 II . 3 d 7 . . . uman s 111 ~ . ~ • ~ . ~.. , as we as protect aga1l1st caspase- an - activatIOn 111 
porcine skin 208. 209. This discrepancy in results may be resolved by taking into account that 
our study was performed in vitro, whilst the experiments pertaining to porcine and human 
skin were in vivo studies. The fact that an immortalised keratinocyte cell line is utilised in 
this study must be considered, as cellular mechanisms may be slightly different to primary 
cells. Furthermore, cells in vivo are in contact with systems such as the neuro-endocrine and 
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lat~ ;][>0ptotic JX>r'ulatiorb in any of the group' of HFbs w," oI>>c'tv~d (f'gurc .1 11)_ It w,,-, 
ot"~r"ed (h31 the lJ V -on ly n"':rOli~ P'll-,ul<~ioll "'a, sigmfic1\JlIl y l;]I'g~" th ;]n the control c~ll, 
(LV-on l)" 23_'JI±4_74% "'_ Conlrol: 5. 14J.2.22'lf, p<O,OS) , The ,;]Ine re'uit wa, wit n ~,,~d 
at.1- h ["",-irradialion, yel lhere ""lS nO dlffer~[l<'e bcN~"1I (h~ lI~c,."'ic [,oplllatio", of lh~ 
<'Onlfol ;]nd UV-only c~l1, (tlgm~ :1 II). Work pcrforll",d by D"li,'I' 1'1 ,,/, (2(X)11 
il1\'c'ljgJI~d th~ ~ff~c' of L:V A on norrml human fihmbla, ts IhM were tran'i~mly tran,kcled 
"ith all ~'I"'e" i on vector e ,>;:,ximg human IhlOred<" in 16), TIJ<:y f ollnd. lhrough ArJl1cx in V / 
propidium iodide ,wining, the thioredo;..in '"'' "bk 10 <ignilic"ntl y ",dllC~ 1i1~ numhef of 
Al1"",in V p'''iti\'e eelb (apop!O!'" "d il l 5 h f>O't -irnl('h'tion with 5 and 10 ll,'m' UVA 










C h "p l ,r' R ~'ul t , J n d D ",'u"i"" 
do,e , ' '''. Zhong: ~1 "I, (200-1) de"''''''trated thJt necm,i, wa' founU to Ix: the pred"",i"",,t 
",,,de "f de~lh ill hum,II' ,"' ,m"1 tlbmhla't' 4 11 P'-l'l irmd,.t iun"", H"we\'~r, the 
excep!ion"ll} hip:h do,e of UV A (11XlO. 2'iOO "nd .,(01 Jh-",'j u",d in Ill<Cir ,tudy mu,t be 
considered '''. Ber""nl et ,,/, (19981 demo",tr~!~d the mode of cell death [II human dermal 
tihrohla'l>. ill;n l';lro rrcon,tructed ,kin. tila( rece ived 25 Jlcm' UVA uooerv.cm apuJ}tu,is 
(6 h po,t -irradl~(i onl 2-", In li oc wit h ll ernerd N al. (1998). the du,e uf 22.3 J/cm ' UV A u<;ed 
III lhi. r~meular ' l lLd)' clearly re:;ul!~d ;n pr~domi"antly apoptut", cell de" lh (figlLre 3, I II. 
The XrI cell "labi li(y a"uy r,'<ulls (tigure ,-1.7) w~r~ expected (0 currelale ",ilh (he 4 h-po\( 
irradiation re'lIlt< ub(aincd ill (hi, n(l'o: I' i,"en!, il "wever!he FA vEe com hi''"tiul1 failed lu 
maimain the ,'i ~hle poPlLla(i"" .l u level ,imilur !O !hJ! of (he comrul (figure 3. 11" This 
di,crer~nc)' eJllplM., i L~' (h~ imp'.'(,H1ce "f u! ili,i",; mul(ipl e (echni~ue., (0 geJJ<:"' I ~ fca\ibk 
re,ull" 
,., ,------------------------------------
u" t-----c - ---
~ II~J 
• I",,' "1'01' 
• .,,,rly"flOp 
, 
i 1I~'bs (2 hi IWbs(4 hl 
I'iguft' .1. 11 (;','pilic r~presel1("lio" of!he pel'cem~g:e, of cdl, ,urtcd illlu (hc ,'uriuu< """ie, 
of ('ell d ~~lh fur 11I-<b, a( 2 h alld 4 h p,,,( -irrudiu(i,,n ., (klermHied h)' Allne~ in VI 
propidiu", iodide 'lalJling, Va h..:, arc c,prc-l-<;cd", u IlClC~II(age of (ile (()(a l c~1I populatioo 










the FA vEe. ,'EC and LlV-oTily cdb h"" in g: significantly ,malin vj,lbk popu l ~lj()m thanl he 
comr,,] cells (FA ,EC: 26.8 1±i3."6'1. ,[le: 41.68± j ~,89'!{-. l:V-oll ly: 42,]2±16.28'k "~So 
Control' M.Q5±2-')7%, rxO,{)5) 11i ~ure .1 12). ['hi, i llu'lrm", that the FA vEe and vEe pre-
treatment i , h", ing no p rolcn; ",' d[coct on ce ll ,i"bihl}, al 12 11 P",(-ur"dialio n, 
1411 
,m 
• "" " u - w 0 • 
" , W 0 
" • • 
" '" " 
JlFbs (11 h l lI Fb, 12-1 h) 
_I,," .1'''1' 
- ."ly"l>Ofl 
Figu rr 3. 12 Graph ic> rq)(c><:lllal iull of I]"" pc'cclllag<'< 01 cC II S ",-,rhod into The varillu< ,node' 
of cdl d.'~ lh fur HFb, al 12 h ""d 2,,\ Ii pel'l · irradiation ~,dete rmined by Anne, ;n VI 
pr'llpidlUlll i"d iM 'lalliing. Vah,e, a"~ e~prew:d a' ~ f'\'rccntagc of 11,,-, IOlal cdl POPU1;l( ioll 
~"d thll~ arc prc,",:ll1cd as mea n ± SIl, ",-,3. 
In the HR:>., " II geon]" had , i gnific~n t1 y 'llldlier viable poplli arion; lh~n lh. COnlrol "e lh 
WV-on ly: 21."17±102'lt y,_ CO!ltro l· ~5_2 1 ±4 _ 5t,%, pdJ.05) at ltie 24 h li me I'Oin l 











23.37±3.029'c vs. vEC: 80.38±1.83%, p<O.OS). All UV -exposed groups had significantly 
larger populations of cells undergoing early apoptosis compared to control cells (UV -only: 
42.2±4.S9c vs. Control: 3.83±O.SI %, p<O.OS). Cells that received vEC pre-treatment had 
significantly less cells undergoing early apoptosis than FA pre-treated and UV-only cells 
(vEC: 9.07±1.479c vs. FA: 39.16±8.2S% and UV-only: 42.2±4.S9C p<O.OS). The FA vEC 
combination treatment group also had significantly less cells undergoing early apoptosis 
than the UV-only cells (FA vEC: 28.S9±3.97% vs. UV-only: 42.2±4.So/c, p<O.OS). HFbs that 
received FA pre-treatment, as well as the UV-only cells, had significantly higher 
popUlations of cells undergoing late apoptosis than all other groups (FA: 28.38±2.7% and 
UV-only: 30.73±6.2S% vs. Control: 8.71±O.S9%, p<O.OS). All groups of HFbs had 
significantly higher numbers of cells undergoing necrosis than the control and vEC-pre-
treated cells (UV-only: 3.71±O.26% vs. Control: O.88±O.14% and vEC: 1.16±O.36%, 
p<O.OS). Based on these results it appears that pre-treatment with vEC is able to afford some 
protection to HFbs against cell death at 24 h post-irradiation. At 2 h post-irradiation the 
mode of cell death in HFbs appears to be necrosis, however by 24 h post-irradiation the 
necrotic populations are negligible. At 24 h post-irradiation the necrotic fibroblast 
popUlation observed at 2 h would no longer be detectable, and 24 h is sufficient to allow for 
the viable population to double 270, 271, which may explain the decrease in the necrotic 
population and increase in the viable population over 2-24 h .. It was determined that pre-
treatment with FA vEC was able to decrease intracellular ROS (figure 3.4), which was 
detected immediately post-irradiation. This decrease in ROS did not correlate to any of the 
specified time points in the mode of death assay, showing that the FA vEC pre-treatment 
may afford initial antioxidant protection to HFbs, yet under conditions of persistent 
oxidative stress may not be sufficient to protect against UV A-induced cell death. However, 
the fact that the protective effect of the vitamins was observed 24 h post-irradiation shows 
that the beneficial effects of certain antioxidant pre-treatment may only be observed at later 
time point, and future studies should include an additional 48 h point to elucidate the true 











Clt"plcr 3 Rc,,, l t, ,nJ Di'l'u"j"a 
As it WetS clt-ar that tI.e HFb , di",layed the mmt re"ctivu y to {.'VA exposure antI induction 
of cdl de~lh r~lhwa y' aft~r 24 h, a detai led analys i.' of thc cfkct of trcatrotcnts on ccll ,kath 
w~, LLmk rla~en Furthermore, a llme-rlcpendem ' nalys is (l-b-l hi of apopto'is ind uccd hy 
I IVA and sul>sequent r['()(~c(jon by the ad dl1 ion of r: A, lI11lividuali y and on co",binat ion with 
vEe is lack ing in IUe ['u me. Two ' portosis-r~lated prol~ in s III HFb, were Ihm "'udied in an 
'ftcmpt 10 cillc itlat~ thc ce llular r"'pomc 10 th e variom trnltrnmt ' m more delai!. I he Bcl-2 
bmily of rrC(~in', compri l ing b,~h ant i- and pro-apoPlotic member>, media te tl.e cel llli ar 
'Iik-or -d~ath' ,wi tch hy reg:ubting: MO.\1!' '''. 2<3 The fami ly memherl Rel- 2 and n." "erc 
'."lcoctl as rcprclclltatlve, of ami- aud pt" <>-apoptotic protem, respectively The Bcl-2: Bn 
rMio is a wcll -know n ,"di~at<x of ,urVI val. with Ihe n lue bemg inversel y rro['011ionai lo the 
lc.d of apopto,;s ~~ 110, N\J, ,\ mount o f prolei~ e~rre"ion wa, determi ned by densilom~lr y. 
ami the ratio subseque nt l) calcu lated (figure 3 I -') 
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I'igllr~ 3,lJ Panel of we,tern blot ~n~ly, es O\ier 2-24 h of the 'rortmic-assoc i ated protc i", 










ChapI'" 1 11.,·,,, 11, a nd Di "'u" i ~n 
Allh" ~ h Ill ne pOlin. Ihere wa, 00 ditfc,en~c in Ih~ Bcl ·2: Rax ratio' in .'ny of Ilk: tr~atm~nt 
1!10ups ,'otnparcJ 10 t h ~ control celt- (ligure 3,14). Pre-treatment ,,"'i(h f'A and vEe. alone Of 
in cornbilui,~r. aPIx-a" 10 have rro cffcd '~1 ~k: BtI-2, B"x r~lio, whl~h rnay l>c ~~p laincd 
b~ Ihc fact Ihal alll'V-apo>-ed gro"p, are prcdomi"''"tly "ndergoing n~nosi> (tigUfC:;, I I). 
in "hie h cd.'~ tn., I:lcl-2; Ba~ ratio would be rend~,~d iITeI~, ant. 
" ,-- ------
, t--
I j--~ 1.5 
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FigUrf 3.14 Bcl ·2: B;l ,\ r/llio delcrmined in HAl, 2 h 1"»I-irnJuialion, Bd-2 and Ba\ are 
~nti - aoo pro· ~poptoli" prot~in' rc:;pcdi\tly . ;\ ratio of:> I il " indi,'al"'c of survival and <I 
it i, indi""I,,e of ~POlllo,i'. V~llIe, .r~ relative to the comro! ~lld d~ta ~re pr"ented a, 
mean ± SD. 11=2. 
Foilowing '" 4 h rem,,"ry ]l<'riod lhere "''"' a lrend lowards '" lowereu >"ni"al r.tlio in lJV-
on]~ cdh 10 I~ conlrol (UV-'~l l ~: Q,7±Q,1 n. COlllrol: 1. 14 1 (figur~ ,.14). 'I'hi, r",,,h 
correlate, to lhe ;\nne~in V!PI dala lh'lI , howeu Ih" UV·only ''ell, had a """II", "iabi" 
pop,,],llion ,·oIIlpan.'u to lhe COrK"'] (figure 3,11). a, wd] a, the XIT ,'iabili ty a"ay 
pcrtorrncd 4 h IX"l irradl"li'~l (figurc 3,7). Intcrc'lirrgiy Ihc ,EC pr,,-trcaleu gw"p had the 
highc,1 Bd·2: Ba,\ fd\io (vEC: 2.21 ±O, 69), Ill<licat ing Ihe "itdlllin, were working to prc\'cnl 
ccll ,lcillh, Although Ihi, effcd dld not correiMc to Ih" XTT a"ay (r.g",e 3,7) 0' Ih" FACS 










FACS at 24 h jlO,(-irn>{lia1>nn (fIgure 3 12l. Althoufh (he &1-2 ""., up-reg ulated arounu .. h 
Pl',t-irrad,,'t1on. ;1> prolcct;vc effect rna y ba\'e onl y t>~ell ub,erveu appro;<imatcly 20 h latcr, 
" ,-----=--=--=-= =--
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~ u 1-----.-- -
~ . 
• £ II..I 
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Control t "A v£C 
t:v 
FAliV 
.. igu ..... .'\. 15 Ikl-2: Bax rmio determined ill Hrb, -I h po'i-irradiation . .8c1-2 and Ba" are 
ami- and pro-apOplOlic pm/em, re<pecuveiy. A ratio of >1 it i, indicative of ",n'ival and" I 
it i, il1dic~IlVe of ~rorto,i.,_ V"lues ~re relat>ve 10 tile cOlllrol and data are prc,cnlcd '" 
mc~n ± SD. 11=2. 
A ,luuy performed by Puufzand d "I. (1<)')7) dcmnn<trMcd that ar..\ h 1""t-UVA eXp'><ure 
(lSOO and 3000 J/cm'l, O'CI'e>pre" ion of 1501-2 in RI> mt f'l1robb'b w .. , ahle to i"hibit 
HjlOpI",i, "'. They hmher ,howed Th ,lt He 1-2 overexpre<>ion led to ~ ,igni f>c'anl J~crea", in 
HO· I Icvch ti,l l(>w ing )(XW) l/cm' UV A ex posure. The)' ,ugge,t lhat Hcl-2 prevent- UV A-
medialed aJ"-.p/,,,i, "" ,uppre""'t) (>f the pmduction or effect, of ROS. The)' h",~ flLnher 
e,ln,poMed Ih.« a" lil(- I<lC~li'atlol1 of Rd-2 i, in the milnchondri., 1 memhr~rle. thi' rna)' he 
I _.,' 1'JI Th the ,i(r of UVA-gerlerJled ROS mvo ,ed in 110-1 acuva!ion .,,"-' apo:'pt'"'' , ~,~ 
fi rilling' ma y ind'caTC " dWll pl1'1""e I"r tile an!i-apoptoIK fk 1-2 
Al 'he 12 h limc J)()lnt (hcrr \!Ia< no ' igniticall( difference in Ihe 1101-2: R"x r~tio be tween 
any of the groops (f>gl're '.161. The,e did ~pp."" (0 be ~n increase in the mlio in tile UV-











high k\cl of pn.>(ec(i,," from "popto,,,_ At 12 h po ,l-irraJiallOh 30'lf of HI'b, were 
umkrgoillg llpopl(t<; j< (figure ,_ 11) "nd althollgh the l:kl-2 : B'LX rlltio is indi""ting 
pr()te~ti()l1, it ,annul h~ .g",,, eJ that "1"'1",,0';' is a mulli-p~lh"'ay pr("~" "nti lln alternate 
palh"ay HI,'>, have r.eefl In lti;Mu (('hpl~r I, figure 1, )3) . 
. ~ 
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Figurt 3.16 B,-' -2: Tlax ralio (\eternllned In HFh, l~ h p",I-irradiatioJl . Bd·2 and ll"x are 
"n!i- ~nJ pm-apoplOlic protein< re'I"'''Tively_ A mtio of > I it i, intJ;C"l;, ~ of ,un i\ "I "Old < I 
il j, .ndicalj\'c of llf"Jl""osis. Y~lues ar~ rdative to lh~ ~()nlrol ",ld Jot" arc prc'CIl\eti a' 
rne<lll ± SIl. ,,=2. 
rw~m~-f()lI[ h,~,T'; post _ irrau ~\li')<l J'c,n ltcti in no ,'",iariOOl betwe~1l the rati", of any grollps 
lng-lire 3, 17). Th~ high~r mtie' in the UV-on ly cell, once again ", g-g~\kJ lhal anotl,,'1' 
apopto.,i, palhw,,}, lila} be ocli,al~d lollowin~ lIVA-exrmure The.,~ re,ult, "e,~ in 
di'''greclllenl wilh lh~ FAC'S tim" thaI .<howed rre-treallllem Wilh "JOe was abl~ 10 prokO 
~gain't cell de"th (fLgllr~ 3.1~). rh" lTV-only 'TIl< nhihit" high 'l\[\'i\';)1 ,atio. which i, in 
direl't contrast 10 lh~ larg-~ mw~,nl e'l' "porto>i' oo,er;'ed h) Annexill Vi 1'1 'laining 
(fig ure.l 12), "~ain illJ,ealing lhal "n "h~malC pathway of "porle"i, tnil~ have h~~n 
innial~d, Bcl -2 alld Bax arc rcl~\ 'IHll 10 Ihi' ,rud)- a, UVA is known 10 jndir"':II}, d,mmgc 
,'cll_ lhrough ROS. which ""'Y IJr~el III;, mi«x'honJrial m~mbrane whcr~ BeI·2 and [>ax 
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30 J/cm\ as well as a reduction in caspase-3 expression and enzymatic activity (at 
20 J/cm 2) 205. Whilst this study examined the antioxidant pre-treatment of skin cells, as 
h d· h d I S6 "09 "9'+· b 'd d I . numerous at er stu les ave one" - . - ,It must e consl ere t 1at post-treatment IS 
potential option, or possible adjuvant therapy, to combating the harmful effects of UV A-
induced photodamage. 
3.4 Conclusions and Future Directions 
3.4.1 Conclusions 
This study aimed to elucidate the protective effects of the antioxidant combination of FA, 
vitamin C and vitamin E against UV A mediated photodamage in human epidermal 
keratinocytes and dermal fibroblasts. The first aim was to determine the optimal 
concentration of FA for human keratinocytes (HaCaTs) and fibroblasts (HFbs and 3T3s). An 
interesting dose-dependent proliferative effect was observed in HaCaTs, yet further studies 
are required to determine the mechanisms involved. The concentration of 0.8 mM FA was 
selected for all cell types, as this proved to be the highest concentration with the least 
amount of damage observed in all cell types. 
The second aim studied the effects of the antioxidant combination on UV A-induced ROS 
generation and lipid peroxidation in HaCaTs and HFbs. Whilst no statistically significant 
effects were observed, it should be noted that pre-treatment of HFbs with FA vEC and 
HaCaTs with vEC resulted in lower amounts of intracellular ROS than cells that received no 
pre-treatment. Pre-treatment with the various treatments had little effect on the lipid 
peroxidation status of both cell types, as determined by the conjugated dienes and TBARS 
assay. Unexpectedly FA vEC pre-treatment of the HFbs appeared to have a detrimental 
effect on lipid peroxidation, as it led to higher levels of diene conjugation and TBARS 
compared to untreated cells. This result will need to be confirmed by additional 
experimental repetitions prior to any conclusions being made. HaCaTs pre-treated with vEC 
resulted in a reduced amount of conjugated dienes compared to cells that received no pre-
treatment, illustrating that the role of the vitamins in reducing ROS may be directly related 











The final aim was to examine the effects of the various treatments on cell viability, and 
subsequently determine the mode of cell death elicited by UV A in HaCaTs and HFbs. The 
various treatments proved to have no significant effect on HaCaTs, HFbs and 3T3s, however 
the FA vEC combination did appear to be providing the HFbs some protection against cell 
death. The treatments did not protect HaCaTs from dying, and the predominant mode of cell 
death appeared to be apoptosis. The mode of cell death employed by the HFbs was 
apoptosis, and in contrast to the cell viability assay, pre-treatment with vEC displayed a 
significantly protective effect against UV A-induced apoptosis. This study was expanded to 
examine the expression of two apoptosis-associated proteins in the HFbs. The ratio provided 
by anti-apoptotic Bcl-2 and pro-apoptotic Bax served as an indicator of survival. The ratio 
was examined over a time course of 2-24 h, and although vEC pre-treated HFbs showed a 
high survival index, this series of experiments served as a reminder that apoptosis is a multi-
pathway process, and other key proteins may need to be assessed in the future. 
Overall, this study highlights that while intensive future work is required, there is enormous 
potential in the use of antioxidant combinations, like that of FA, vitamin C and vitamin E, as 
possible adjuvant therapies against UV A-mediated photodamage. 
3.4.2 Future Directions 
As with any research project, retrospect is often 20-20 VISion, and this section aims to 
suggest improvements to benefit future studies. Firstly, there are many variations in current 
irradiation studies performed on human skin cells. Numerous variables are associated with 
irradiation conditions, including irradiation doses (5- 5000 llcm\ irradiation medium (PBS 
or colourless medium), irradiation time (0-3 h), wavelengths emitted (320-400 nm for UV A) 
and temperature at which the cells are maintained (4- 3TC). Primary cell cultures vary in 
the age of the donor (neonatal- 88 yrs), site of origin (e.g. foreskin, breast tissue), culture 












Whilst elucidating the optimal concentration of FA in HaCaTs, a dose-dependent 
proliferative effect was observed, which could be further examined by assessing cell 
numbers (manually counting cells using a Coulter counter), or by monitoring 
bromodeoxyuridine (BrdU) incorporation into the DNA. FACS analysis could also be 
performed to determine if FA lead to alterations in cell cycle arrest! progression. 
As previously mentioned the irradiation conditions in this study could be altered to ensure 
that cells undergo irradiation in the minimum amount of time possible. An improved light 
source with greater spectral power (to decrease the irradiation time), and a thermo-stabilizer 
plate to maintain a suitable temperature, should be used in future irradiation studies. 
The phase contrast microscopy examining cell morphology post-irradiation allowed for the 
visual examination of the effects induced by UVA exposure. Cells could be further analysed 
using a nuclear dye such as 4',6-diamidino-2-phenylindole (DAPI) or Hoechst which would 
have enabled the visualisation of any UV A-induced DNA damage. In an attempt to correlate 
UV A-induced ROS formation and DNA damage cells could be co-stained with DHR 123, 
and visualised through fluorescent microscopy. 
To determine whether the antioxidant treatments were able to attenuate UVA-induced lipid 
peroxidation, the conjugated dienes and TBARS assays were performed. No significant 
results were established, and this may be due to numerous reasons, one of the most likely 
being the extremely low amount of lipid obtained from near-confluent 10 cm2 dishes (0.2-
2 mg), some possibly lost through the extraction process. In addition, the number of 
biological and technical repeats needs to be increased to establish feasible trends. Other 
techniques may include detection of peroxidation products through HPLC or western blot 
analysis. These methods of lipid peroxidation analysis they may be superior to the TBARS 












In order to strengthen the western blot results, additional end-stage apoptotic markers, such 
as caspase-3, could have been included. Altcrnate options to determining cell death may also 
include caspase activity assays or lactate dehydrogenase (LDH) release assays to study 
apoptosis and necrosis respectively. What remains intriguing is that exposure to UVA 
undoubtedly leads to cell death, however the mode of cell death maybe be influenced by 
various antioxidant treatments. 
Discrepancies between in vivo and in vitro studies point towards the need for a unified 
model. Organotypic cultures and 3D in vitro reconstructed skin models are ideal for 
studying the effects of antioxidant treatments. These systems allow neighbouring cells to 
interact, yet at the same time be isolated and studied individually. The encouraging findings 
of topical FA vEe pre-treatment witnessed in in vivo studies 208. 209. 210 still needs to be 
extrapolated to an in vitro environment in order to elucidate the cellular mechanisms at play 
in response to antioxidants such as FA. The in vitro examination of the FA vEe solution 
would be valuable in that the treatment appears to effect cells in a cell-type specific manner. 
Future work involving the FA vEe solution would be to first establish a 3D co-culture 
model before examining the effects on lipid, DNA and protein damage, as well as the effects 













A.I Cell Culture Reagents 
A.I.1 Dulbecco's Modified Eagle's Medium (DMEM) 
DMEM- 21: 
27.06 g DMEM powder medium (Highveld Biological Pty. Ltd., JHB, RSA) 
7.4 g NaHC03 
Adjust pH to 7.4 
Make up to 2 I with autoclaved ddH20 
Sterilise through a 0.2 /-lm filter and store in 400 ml aliquots at 4"C 
A.1.2 Fetal calf serum (FCS) 
Heat the bottle of FCS (Highveld Biological Pty. Ltd., JHB, RSA) once at 56"C for 20 min 
to inactivate complement factors. 
Store in 50 ml aliquots at -20°C 
A.I.3 Penicillin! Streptomycin 
Final concentration: Penicillin G sodium salt (Sigma-Aldrich, Schnelldorf, Germany) 
100 Ulml; Streptomycin sulphate salt (Sigma-Aldrich, Schnelldorf, Germany) 100/-lg/ml 
lOOX penicillin/ streptomycin- 1 I: 
Dissolve 6 g penicillin and 109 streptomycin in 1 I autoc1aved ddH20 











A.1.4 lOX Phosphate buffered saline (PBS) 
lOX PBS- I I: 
80 g NaCI (1.37 M) 
2 g KCI (0.03 M) 
12.6 g Na2HPO-l anhydrous (0.09 M) 
2 g KH2PO-l (0.01 M) 
Make up to I I with ddH20 and store at room temperature 
Dilute to IX with ddH20 and autoclave before use 
A.1.S Trypsinl ethylenediaminetetraacetic acid (EDTA) 
0.05% Trypsin (Difco, Lawrence, USA)! 0.02% EDTA (Sigma-Aldrich, Schnelldorf, 
Germany) 
0.05% Trypsin/ 0.02% EDTA- 100 ml: 
0.05 g Trypsin 
0.02 g EDT A anhydrous 
Dissolve trypsin in 100 ml autoclaved I X PBS, then dissolve EDT A 
Sterilise through a 0.2 I-lm filter and store in 20 ml aliquots at -20°C 
A.1.6 EDTA 
0.05% EDTA- 100 ml: 
0.05 g EDT A anhydrous 
Dissolve in 80 ml autoclaved IX PBS and adjust to pH8 
Make up to 100 ml 











A.1.7 Cell Fixative 
Glacial acetic acid (Associated Chemical Enterprises Pty. Ltd., JHB, RSA) and methanol 
(Saarchem (Merck), JHB, RSA) were prepared in a 1:3 ratio. 
Fixative- 100 ml: 
25 ml glacial acetic acid 
75 ml methanol 
A.1.8 Hoechst No. 33258 
Hoechst No. 33258 trihydrochloride (2' -[4-hydroxyphenyl]-5-[ 4-methyl-I-piperazinyl]-
2,5' -bi-I H-benzimidazole) (Sigma-Aldrich, Schnelldorf, Germany) 
Stock solution- 100 ml: 
5 mg Hoechst No. 33258 trihydrochloride 
100 ml IX PBS 
Stored (wrapped in aluminium foil) at 4°C 
Working solution (final concentration 0.5 !lg/ml)- 100 ml: 
I ml Hoechst stock solution 
99 mllX PBS 
Stored (wrapped in aluminium foil) at 4°C 
A.1.9 Citric acid- disodium phosphate buffer (mounting fluid) 
Mounting fluid- 100 ml: 
22.2 ml 0.1 M Citric acid (1.92 g citric acid made up to 100 ml with ddH20) 











50 ml glycerol 
Adjust to pH5.5 and store at 4°C 
A.1.10 4% Paraformaldehyde (PFA) 
4% PFA- 100 ml: 
4 g PFA (Spi-Chem, Westchester, PA, USA) 
Make up to 100 ml with 1 X PBS and heat at 50°C to dissolve 
Stored in 10 ml aliquots at -20°C 
A.1.1.11 XTT Reagent 
XTT Cell Proliferation Kit II (Roche, Gennany) 
Working Reagent- 5 ml: 
4900 fll XTT labeling reagent 
100 fll Electron coupling reagent 
A.2 Antioxidants 
A.2.1 Ferulic acid 
Ferulic acid (Sigma-Aldrich, Schnelldorf, Germany) was made as a 10 mM stock solution. 
Ferulic acid (10 mM) - 10 ml: 
0.01942 g ferulic acid 
400 fll absolute ethanol 
9.6 ml sterile IX PBS 











A.2.2 Vitamin E 
35 mM Vitamin E stock- 10 ml: 
151,5 jll dl-a-Tocopheryl acetate (Vitamin E) (Roche- DSM Nutritional Products, 
Switzerland) 
10 ml Absolute ethanol 
Stored in 500 jll aliquots (wrapped in aluminium foil) at _20DC 
Cells were exposed to a final concentration of 35 jlM Vitamin E 
A2.3 Vitamin C 
5 mM Vitamin C stock- 10 ml: 
0.0099 g Sodium I-ascorbate (Vitamin C) (Allied Drug Company, Pty. Ltd., Durban, RSA) 
10 ml IX PBS 




Cells were exposed to a final concentration of 50 jlM Vitamin C 
A.3 Flow Cytometry Reagents 
A.3.2 Dihydrorhodamine 123 (DHR 123) 
10 mg/ml (28.8 mM) DHR 123 stock solution- I ml: 
Reconstitute 10 mg DHR 123 (Molecular Probes®, Invitrogen, Eugene, OR, USA) 
1 ml DMSO 











I mM DHR 123 working stock- I ml: 
34.7 fll 10 mg/ml DHR 123 
965.3 fll DMSO 
Store in 1 ml aliquots (wrapped in foil) at -20
o e 
10 flM DHR 123 working solution -1 ml: 
10 fll IOflM DHR 123 
990 fll complete medium 
To be made fresh before use 
A.3.3 Annexin V 
Fluorescein isothiocyanate conjugated Annexin V (Annexin V -FITC) requires a usage of 
5 fll/ test (as per manufacturer's instructions). 
A.3.4 Propidium Iodide 
1 mg/ml Stock solution- 25 ml: 
Reconstitute 25 mg stock powder (Sigma) in 25 ml ddH20 
Store in I ml aliquots (wrapped in foil) at -20 oe 
50 flg/ml Working solution- 1 ml: 
50 fll 1 mg PI stock solution 
950 fll IX PBS 












A.3.S Annexin V binding buffer 
IX Annexin V binding buffer- 100 ml: 
0.2383 g 10 mM Hepes (pH7.4) 
0.812 g 140 mM NaCI 
0.037 g 2.5 mM CaCh 
Make up to 100 ml with ddH20 and store at 4°C 
A.4 Lipid Peroxidation Reagents 
A.4.1 Saline 
0.9% Saline solution- 100 ml: 
0.9 g NaCI 
Make up to 100 ml with ddH20 
A.4.2 FeCh 
0.27% FeCh solution- 100 ml: 
0.27 g FeCl3.6H20 
Make up to 100 ml with ddH20 
A.4.3 Butylated hydroxy toluene (BUT) 
0.22% BHT solution- 100 ml: 
0.22 g BHT 
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A.4.4 Glycine buffer 
0.2 M Glycine.HCI buffer pH3.6- 1 I: 
IS g Glycine 
800 ml ddH20 
Adjust to pH3.6 (HCI), make up to I I with ddH20 and store at 4°C 
A.4.S Thiobarbituric acid (TBA) 
0.5% TBA solution- 10 ml: 
0.05 gTBA 
0.03 g SDS 
10 ml ddH20 
To be made fresh before use 
A.S Protein Expression Reagents 
A.S.I Radio-Immunoprecipitation Assay (RIPA) buffer 
Incomplete RIP A buffer: 
150 mM NaCI 
I % Triton X-lOO 
0.1% SDS 
20 mM Tris (pH7.5) 
I % Deoxycholate 
H20 











Incomplete RIP A buffer stock- 50 ml: 
1.5 ml5 M NaCI 
500 III 100% Triton X-IOO 
500 III 10% SDS 
1 ml I M Tris (pH7.5) 
0.5 g Deoxycholate 
46.5 ml H20 
Sterilise through a 0.45 11m filter and store in 5 ml aliquots at 4°C 
A.5.2 Complete RIPA extraction buffer 
Complete RIPA reagent- 3 ml: 
120 III Complete proteinase inhibitor cocktail 
3 III Aprotinin 
15 III PMSF 
3 III Pepstatin A 
2859 III RIP A buffer 
Make fresh before use 
Use 150 III per 100 mm dish 
A.S.3 Bovine serum albumin (BSA) 
Bovine serum albumin fraction V (Roche, Mannheim, Germany) 
2 mg BSA solution- 10 ml: 
2 mg BSA powder 












A.s.4 Bicinchoninic acid (BCA) working reagent 
BCAT~[ Protein Assay Kit (Thermo Scientific, Pierce, Rockford, IL, USA) 
BCA working reagent- 10 ml: 
9.S ml Reagent A (supplied) 
0.2 ml Reagent B (supplied) 
To be made fresh before use 
A.5.s Resolving gel buffer 
1.5 M Tris.HCl pHS.9/ 0.4% SOS- 200 ml: 
36.2 g Tris 
0.8 g SOS 
Adjust to pH 8.9, make up to 200 ml with ddH20 and store at 4°C 
A.5.6 15 % Resolving gel 
1 x 1.5 mm 15% resolving gel: 
3 ml Resolving buffer 
4.5 ml Acrylamidelbis-acrylamide (30% solution) (Sigma-Aldrich, Schnelldorf, Germany) 
1.5 ml ddH20 
180 III Fresh 10% ammonium persulphate 
IS III N,N,N',N'-Tetramethylrthylendiamin (TEMEO) 











A.S.7 Stacking gel buffer 
0.5 M Tric.HCI pH6.8/ 0.4% SDS- 100 ml: 
5.9 g Tris 
0.4 g SDS 
Adjust to pH 6.8, make up to 100 ml with ddH20 and store at 4°C 
A.S.S 5 % Stacking gel 
I x 1.5 mm 5% stacking gel: 
1.5 ml Stacking buffer 
I ml Acrylamide/ bis-acrylamide (30% solution) (Sigma-Aldrich, Schnelldorf, Germany) 
3.5 ml ddH20 
60 ).tI fresh 10% Ammonium persulphate 
6 )11 N,N,N' ,N' -Tetramethylrthylendiamin (TEMED) 
Insert comb immediately after pouring the gel (there should be I cm of stacking gel between 
the bottom of the comb and the resolving layer) 
Allow a minimum of I hr for polymerisation before removing the comb 
A.S.7 Loading dye 
5X Stock loading dye- 50 ml: 
1.75 g Tris 
30 ml Glycerine 
Make up to 40 ml with ddH20 and adjust to pH 6.8 
5 g SDS 












Fresh loading dye- 200 fll: 
100 fll 5X Loading dye 
50 fll ~-Mercaptoethanol 
50 fll 0.025% Bromophenol blue 
Diluted to I X accordingly for individual protein samples 
A.S.8 Tank buffer 
lOX Tank buffer stock- I I: 
30.2 g Tris 
144 g Glycine 
10 g SDS 
Make up to 1 I with ddH20 and store at room temperature 
I X Tank buffer working solution- I I: 
100 ml lOX Tank buffer stock 
900 ml ddH20 
A.S.9 Transfer buffer 
lOX Transfer buffer stock- I I: 
144 g Glycine 
38 g Tris 












IX Transfer buffer working solution- I I: 
lOO ml lOX Transfer buffer 
200 ml Methanol 
To be made fresh before use 
Cool to 4°C before use 
A.S.IO Tris-buffered saline with tween (TBS-T) 
lOX TBS-T stock- I I: 
60.5 g Tris 
87.6 g NaCI 
Adjust to pH 7.4 
Make up to I I with ddH20 and store at room temperature 
IX TBS-T working solution- I I: 
100 ml lOX TBS-T stock 
I ml Tween20 
A.S.U Fat-free milk 
5% Fat-free milk solution- 10 ml: 
0.5 g skim milk powder 
Make up to 10 ml with TBS-T 
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A.S.l2 Chemiluminescent substrate 
SuperSignal® West Pica Chemiluminescent Substrate (Thermo Scientific, Pierce, Rockford, 
IL, USA) 
Chemiluminescent working reagent- 2 ml: 
I ml Stable peroxide solution (supplied) 
1 ml Luminal! enhancer solution (supplied) 
To be made fresh before use 
A.S.13 Developer 
Developer working solution- 500 ml: 
100 ml Developer (AGFA Healthcare, Belgium) 
400 ml H20 
Store in the dark at room temperature 
A.S.14 Fixer 
Fixer working solution- 500 ml: 
100 ml Fixer (Illford Rapid Fixer, AGFA Healthcare, Belgium) 
400 ml H20 
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B. 1 Mycoplasma Testing 
Appendix B 
Mycoplasma, a genus of bacteria that lack cell walls, are mostly unaffected by antibiotics 
such as penicillin 295. Every alternate passage, cells were set aside for mycoplasma testing. 
Cells were grown on coverslips (22x22 mm, Marienfeld, Lauda-Konigshofen, Germany) in 
35 mm2 dishes for approximately 3 days. Medium was removed and cells were rinsed with 
IX PBS before being placed in a fixative solution (Appendix A) for 5 min. Hoechst working 
stock (Appendix A) was added to the fixed cells for 6 min in the dark at room temperature. 
The coverslip was rinsed with I X PBS and mounted onto a slide (Marienfeld, Lauda-
Konigshofen, Germany) using mounting fluid (Appendix A). Slides were viewed using the 
DAPI filter (excitation: BP 365/12; emission: LP 397) on the fluorescent microscope (Zeiss 
Axiovert 200M). 
B.2 Cell Counting 
Trypsinized cells were re-suspended in 4 ml of complete medium in a 15 ml tube. A 
coverslip was placed onto the haemocytometer (Neubauer improved bright-line, Marienfeld, 
Lauda-Konigshofen, Germany) and 8 fil of suspended cells was placed on both halves of the 
haemocytometer. Cells in two quadrants on each half of the cytometer were counted and the 
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